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The key entry point of most membrane proteins into the lipid bilayer is the 
Sec61/SecYEG translocon, that mediates the transfer of hydrophilic sequences across 
the membrane and integration of mostly apolar a-helical transmembrane domains into 
the lipid bilayer. Three distinct integrations steps can be distinguished: (1) a first 
hydrophobic signal sequence targets the protein to the translocon, integrates itself into 
the membrane, and initiates translocation of the downstream polypeptide. (2) A 
subsequent hydrophobic segment laterally exits the translocon into the bilayer and thus 
stops further transfer. (3) The next hydrophobic sequence triggers re-integration into 
the translocon, re-initiating polypeptide transfer. Successive stop-transfer and re-
integration sequences result in complex multispanning proteins. The major determinant 
of membrane topology appears to be the hydrophobicity of transmembrane domains. 
This has been best demonstrated for potential stop-transfer segments, suggesting a 
sequence-autonomous thermodynamic equilibration between the hydrophilic 
environment of the translocon and the apolar lipid phase.In this thesis, we analyzed in 
detail the hydrophobicity threshold for a potential re-integration TM domain 
downstream of different cytoplasmic loop sequences. Surprisingly, we discovered a 
strong dependence on the length of this cytoplasmic sequence. Short sequences are 
facilitating re-integration, while long ones seem to impede it. This demonstrates, that 
re-integration is not independent from the sequence-context. Further investigations 
revealed that loop sequences containing isolated folding domains, intrinsically 
disordered sequences, or sequences with a high affinity for chaperones enhance the re-
integration efficiency, whereas those with low affinity to chaperones, and fragments of 
natural protein domains impair re-integration. We propose that the latter sequences, as 
they collapse to molten globules – i.e. near-native conformation of high compactness 
with already pronounced secondary structure and increased amount of hydrophobic 
residues on the surface area – compete with the translocon for interaction with the 
potential transmembrane segment. Our results thus define the environment of the 
nascent polypeptide chain when re-integration can occur and may serve as a guide in 
de novo membrane protein design. 
In a second part, we characterized the antiviral natural product cavinafungin as an 
inhibitor of signal peptidase for Dengue virus as well as host substrates, inhibiting 
biogenesis of viral proteins from a single precursor membrane polyprotein. 
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1.1. Protein biogenesis in eukaryotic cells 
 
Proteins were first described in the 18th century as an own class of biomolecules by 
Antoine Fourcroy. He first named them albuminoids, because of the similar 
characteristics of these biomolecules to egg albumin. In 1833 the chemist Gerardus 
Johannes Mulder discovered that the elemental analysis of egg albumin, fibrin and 
wheat gluten all resulted in basically the same empirical formula, suggesting that all 
these biomolecules are made up of one basic substance. However, the exact nature and 
function of proteins long remained elusive. While some amino acids were discovered 
already in the 19th century, only in the beginning of the 20th century it was stated by the 
german chemists Emil Fischer and Franz Hofmeister that proteins are mostly made up 
of amino acids. In the 1920s it was shown by James Sumner that the enzyme urease is 
a protein, appointing the first enzymatical function to a protein itself (Tanford and 
Reynolds, 2003).  
Today we know that proteins fulfill a plethora of functions in a cell and are not only 
catalyzing numerous reactions, but are also involved in the regulation of an organism`s 
homeostasis, fulfill structural functions in the shaping of a cell, and act as transporters 
for other proteins, molecules and a great number of external signals. 
Not only the function of proteins was of great interest for scientists during the last 
century, but also how proteins exist in a physiological environment. The first hypothesis 
that proteins are not just long polypeptide chains in solution, but are folding in three 
dimensions, was already established in the 1930s by William Astbury and others. In 
1951, Linus Pauling proposed two different secondary structure elements: a- and b-
type (Eisenberg, 2003). Alpha-helicity is a secondary structure that is energetically 
favored when compared to an unfolded sequence, due to an energetic sink resulting 
from the hydrogen-bond formation between the peptide bonds i and i+4. The helicity 
resulting from this hydrogen-bond formation buries the peptide bonds in the core or 
backbone of the secondary structure, while the amino acid side chains are oriented to 
the solvent. The different properties of each amino acid side chain make the a-helix an 
ideal secondary structure, since the characteristics of the helix can be modulated to 
match the characteristics of the solvent and other parts of the protein. The second 
secondary structure motif is called b-sheet and is made up of several b-strands. While 
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hydrogen-bonds in a-helices are formed within the strand, the hydrogen-bonds in b-
sheets are formed between two b-strands, that are oriented towards each other either 
parallel or anti-parallel. In contrast to a-helices, the b-sheet is a nearly extended 
conformation, having the polypeptide backbone stretched and the amino acid residues 
pointing into opposite directions (Eisenberg, 2003).  
A leading experiment in the field of protein folding was performed in 1961 by the group 
of Christian B. Anfinsen. His group revealed that the folding and unfolding process of 
ribonuclease A is reversible. Upon treatment with reducing and denaturing agents the 
protein unfolds and loses all enzymatic activity. After removal of these agents the 
protein refolds and regains enzymatic function (ANFINSEN et al., 1961). These 
findings lead to the thermodynamic hypothesis: the folding information of small 
domains is only encoded within the amino acid sequence and is not determined by 
external features. It states, that the native state of a protein corresponds to its free energy 
minimum. A totally unfolded and thus unstructured domain is high in energy, due to 
the exposure of hydrophobic amino acids into a hydrophilic environment. Several 
models were proposed to describe what happens during the early states of folding 
(Udgaonkar, 2013): 
• The framework model: Protein folding is initiated by secondary structure 
formation, tertiary structures form due to diffusion and collision of the 
polypeptide (Ptitsyn, 1973). 
• The nucleation model: Formation of native secondary structure elements starts 
locally at a nucleation point in the protein and is propagated through the 
polypeptide until the whole protein is folded (Wetlaufer, 1973). 
• The hydrophobic collapse model: The unfolded polypeptide first collapses into 
a molten globule-state, due to the energetic pressure caused by the exposure of 
hydrophobic residues to the cytosol. Folding into the native structure is achieved 
by rearrangement of the molten globule-state into the native protein fold 
(Brylinski et al., 2006).   
• The nucleation-condensation model: The model tries to unify the 
abovementioned models. Secondary and tertiary structures are formed 
simultaneously (Fersht, 1995).  
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These models are not mutually exclusive and are often pointing out extreme cases of 
protein folding that do not rule out other possibilities. In each of these models the 
folding process points towards low energy, resulting in a state that is called a molten 
globule (Ohgushi and Wada, 1983).        
A molten globule is by definition a near-native conformation of high compactness with 
already pronounced secondary structure but only little tertiary structure interactions. It 
still exposes hydrophobic amino acids on the surface. The folding funnel diagram is 
providing a model for the driving-forces of folding (Figure 1). 
 
Figure 1: Folding funnel diagram. The free energy E for unfolded proteins is high as well as the number of possible 
conformations. The polypeptide reduces its free energy  and the number of possible conformations by collapsing 
into a molten-globule. Rearrangements lead to the native conformation. Adapted from (Onuchic et al., 1997)    
 
However, in the physiological environment of a living cell, this simple model of protein 
folding needs modifications. In vivo, proteins are normally synthesized in the 
cytoplasmic environment of a cell on ribosomes by translation of mRNA and do not 
fold independent of the translational process, since the codon translation rate is much 
slower than the folding rate (Fedorov and Baldwin, 1997). Furthermore, the co-
translational folding of proteins is restricted by a 100 Å long ribosome exit tunnel that 
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can cover 30 – 40 amino acids, and thus prevents folding (Malkin and Rich, 1967). 
Although co-translational formation of secondary structures can already occur in the 
ribosome and even complete small domains, like zincfinger motifs, have been shown 
to form within the ribosome exit tunnel (Marino et al., 2016; Nilsson et al., 2015b), 
large domains in statu nascendi with only partial exposure of the domain sequence to 
the cytosol cannot fold into their native structure. 
Furthermore, in living cells a problem emerges that is only of minor importance when 
characterizing folding in the test-tube. The high density (300-400 mg/ml biomolecules) 
in the cellular environment increases the possibility of a nascent chain polypeptide to 
interact with other proteins (Ellis and Minton, 2006). Although the collapse of a 
polypeptide chain in general happens very fast, the folding pathway to the native state 
can be energetically hindered, resulting in kinetically trapped intermediates, which 
expose hydrophobic amino acids to the cytosol that are prone to aggregation. To avoid 
this, a class of proteins have emerged that recognize these hydrophobic stretches, 
passively aid in folding and prevent aggregation: chaperones. Many chaperones have 
been identified as heat shock proteins (Hsps). The Hsps are upregulated upon heat 
shock to protect heat-destabilized proteins from aggregation (Kim et al., 2013a). The 
different classes of Hsps were named after their molecular weights: Hsp40s, Hsp60s, 
Hsp70, Hsp90s, and Hsp100s, with the Hsp70 chaperones being the best characterized. 
They function via an ATP/ADP-cycle (Figure 2).  
The ATP-bound open conformation of Hsp70 chaperones is screening substrates for 
hydrophobic stretches. Hsp40 co-chaperones often recruit unfolded proteins to Hsp70. 
The so-called J-domain of Hsp40 chaperones interact with the ATPase domain of 
Hsp70 and stimulates hydrolysis of ATP to ADP. The ADP-bound closed conformation 
of Hsp70 chaperones is binding to the unfolded protein. Upon ADP-ATP exchange, 
which is catalyzed by nucleotide-exchange factors, the polypeptide is released and a 





Figure 2: ATP-dependent Hsp70 chaperone cycle. The ATP-bound Hsp70 chaperone is screening polypeptides for 
unfolded stretches with a high on/off rate. Hsp40 co-chaperones are often recruiting unfolded polypeptides to the 
Hsp70 chaperone and are mediating the hydrolysis of ATP to ADP, which leads to an closed conformation, where 
the unfolded protein stretch is hidden inside the chaperone, making it unable to aggregate with other proteins. 
Nucleotide-exchange factors reopen the chaperone and the substrate is released. (Kim et al., 2013a). 
 
Importantly, binding of proteins to an unfolded polypeptide itself does not facilitate 
efficient folding, but is limiting the concentration of unfolded intermediates, thus 
decreasing the possibility of protein aggregation. Chaperones do so by assisting in 
protein folding in basically every step of protein synthesis, starting already at the 
ribosome. Ribosome-associated Hsp70-chaperone (RAC in yeast, Hsp70L1 in 
mammals) and nascent-chain associated chaperone (NAC in archaea and eukaryotes) 
aid the polypeptide during the earliest stages of protein synthesis, when the nascent 
chain emerges from the ribosomal exit tunnel and is exposed to the cytosolic 
environment (Preissler and Deuerling, 2012). The exact mechanism is still elusive and 
the function of many chaperones might be redundant. It was shown that both, ribosome-
associated chaperones (RAC) and soluble chaperones bind to nascent chains, keeping 
them in a partially unfolded conformation to prevent misfolding and aggregation until 
larger parts of the protein have been synthesized, ensuring cooperative domain folding 
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(Kim et al., 2013a). Upon protein synthesis into the cytosol, the nascent chain is further 
chaperoned by other cytosolic Hsp70-Hsp40 chaperones, like Ssa1-4 (in yeast) (Bukau 
et al., 2000). Some proteins are transferred to so-called chaperonins post-
translationally. Chaperonins are large complexes (800 – 1000 kDa) with a central 
cavity, that allow the polypeptide to fold in a protected environment (Bukau and 
Horwich, 1998).  
Notably, Hsps do not only prevent misfolding and aggregation of proteins until they are 
correctly folded in the cytosol. When proteins fail to fold they are degraded via the 
ubiquitin-proteasome system (UPS), a process that also requires the binding of 
chaperones to the polypeptide (Chakrabarti et al., 2011).  
 
Proteins in a living organism have to fulfill many inter- and intracellular functions. 
Several membrane-enclosed organelles (e.g. endoplasmic reticulum, mitochondria, 
peroxisomes, nucleus) provide specific environments, where specialized enzymes are 
responsible for specific maturation steps. Due to the compartmentalization of the 
eukaryotic cells, most proteins are not resident in the cytosol and therefore have to pass 
at least one intracellular membrane barrier (Schatz and Dobberstein, 1996). However, 
the transport of folded proteins into intracellular compartments is rarely observed. 
Instead, the folding process is often uncoupled from protein transport and is delayed 
until the protein reaches a non-cytosolic compartment. This is achieved via two 
different translation and translocation mechanisms:  
• Co-translational translocation of nascent proteins, coupling the translation 
process to the transport of the polypeptide inside the endoplasmic reticulum 
• Post-translational translocation of completed proteins that are kept in a folding-
competent state by chaperones 
 
Transport into most organelles occurs post-translationally, with the help of chaperones, 
that keep the nascent chain in an unfolded but folding-competent state. An exception is 
the transport of polypeptides into the endoplasmic reticulum, where translocation 
mostly occurs co-translationally and only a fraction of proteins, mainly in bacteria and 
yeast, is trafficked via post-translational pathways. In mammalian cells, only small 
polypeptides are targeted post-translationally to the ER (Lakkaraju et al., 2012) and the 
co-translational pathway is the major route of protein transport into the ER and beyond. 
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1.2. Co-translational SRP-dependent targeting into the ER 
 
 
Co-translational SRP-dependent targeting into the endoplasmic reticulum is one way to 
transport proteins across the ER membrane. The protein is targeted and translocated in 
statu nascendi via the pore-forming membrane protein Sec61 to the luminal site of the 
endoplasmic reticulum, thus most of the folding process only occurs after the protein 
has reached the ER lumen. To ensure specific targeting, proteins contain molecular 
labels, mostly on an amino acid level, which direct them to the corresponding 
compartments. One of the most common labels is the N-terminal signal sequence or 
signal peptide for targeting to the endoplasmic reticulum. The signal sequence is not 
necessarily preserved after targeting. Especially for soluble proteins it is cleaved off by 
the signal peptidase. Although the sequence homology between different signal 
peptides is very low, they share several loosely defined properties (Nilsson et al., 
2015a) (Heijne, 1990).  
• The length of a signal peptide is between 16 – 30 amino acids  
• The N-terminal region (n-region, 1 – 5 amino acids) is rich in lysines and 
arginines, and therefore positively charged. 
• The middle part (h-region, 7 – 15 amino acids) is the hydrophobic core of the 
sequence. The hydrophobic amino acids are crucial for efficient targeting and 
translocation.  
• The C-terminal region (c-region, 3 – 7 amino acids) has mostly polar amino 
acids and is important for signal cleavage. The (-3,-1)-rule states that amino 
acids in position one and three upstream of the cleavage site  must be small,  
neutral residues. Importantly, the amino acid at position +1 must not be proline.  
 
Signal sequences mediating co-translational targeting are recognized by the signal 
recognition particle (SRP). Even though the general function of SRP is highly 
conserved in all domains of life, its structural composition is different, with an 
increasing complexity from bacteria (Ffh) to yeast and mammals (Pool, 2005). 
Mammalian SRP is a ribonucleoprotein, consisting of a Y-shaped 7SL RNA and six 
protein subunits (SRP9, SRP14, SRP19, SRP54, SRP68 and SRP72). Yeast SRP 
consists of a 11S RNA, a SRP14 homodimer, a yeast specific SRP21, SRP68p, SRP54p 
and Sec65p (Pool, 2005). Both SRPs have in common that they can be divided into two 
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structural domains: The S-domain, which recognizes the signal peptide and the Alu-
domain, which is thought to be responsible for translational arrest (Bacher et al., 1996; 
Siegel and Walter, 1986). A schematic representation of both SRPs is found in Figure 
3 A. SRP54 plays an important role for co-translational targeting, since it is in close 
contact to the ribosomal exit site, enabling emerging signal peptides to bind to its 
methionine-rich M-domain (Keenan et al., 1998). The N-terminal part of SRP54 folds 
in a characteristic four-helix bundle, followed by a GTPase domain (NG-domain). M 
and NG-domain are connected via a highly flexible linker, allowing SRP to undergo 
major conformational changes during the targeting process (Nyathi et al., 2013). How 
SRP binds to the ribosome is shown in Figure 3 B. In mammalian cells, binding of SRP 
to the signal peptide leads to an SRP9/14-mediated elongation arrest, keeping the 
majority of the nascent chain in the chaperone-like environment of the ribosome tunnel, 
thus preventing the protein from premature folding and aggregation (Mason et al., 
2000). In a next step, the complex is targeted to the endoplasmic reticulum by binding 
to the ER-bound heterodimeric SRP receptor (SR, FtsY in bacteria), consisting of a 
70kDA SRa and a 30 kDA SRb subunit. The C-terminal part of SRa shows high 
homology to the NG-domain of SRP54, including the GTPase functionality. The b 
subunit  also has an Arf-like GTPase-domain (Miller et al., 1995), which facilitates 
strong SRa-b association in its GTP-bound state. Possibly, Sec61b acts as a nucleotide 
exchange factor, thus activating SRb for binding with SRa (Helmers et al., 2003). 
Interaction between SRb and the yeast Sec61 homologue Ssh1p has been verified, as 
well as targeting defects and growth defects upon disruption of this interaction, 
suggesting that targeting to the endoplasmic reticulum is dependent on the interplay of 
these two proteins ((Jiang et al., 2008), (Helmers et al., 2003)).  
Interestingly, unlike classical GTPases, where activation and inactivation is triggered 
via binding and hydrolysis of GTP, the pairing of SRP and SR is regulated via a 
nucleotide-dependent dimerization cycle (Gasper et al., 2009). The mechanisms of 
dimerization and targeting were deeply analyzed in bacteria. Both, Ffh and FtsY, were 
found inactive, even in an open GTP-bound state, due to structural impairments. Only 
upon dimerization and targeting the GTPase activity is established over a cascade of 
conformational changes (Peluso et al., 2001). Importantly, the dimerization and 
activation process requires the presence of a ribosome-nascent chain complex (RNC) 
to be efficient, by on the one hand disfavoring the rearrangement of the GTPases to a 
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closed and activated state by forming a highly stabilized early targeting intermediate, 
and on the other hand by accelerating the formation of the RNC-SRP-SR complex 
1000-fold (Peluso et al., 2000; Zhang et al., 2009). These stabilizing and accelerating 
effects are preventing abortive reactions of the targeting process. At the end of the 
targeting, the RNC is handed over to the translocon, resulting in a new cascade of 
conformational changes in the GTPases, leading to a so-called closed state. Intense 
biochemical and crystallization studies in bacteria demonstrated that amino acids in 
loops seven and nine of SecY are interacting with the ribosomal proteins L23 and L35, 
which are located at the ribosomal exit site. However, how the exact unloading 
mechanism of the RNC-SRP-FtsY(SR) complex to the translocon works is still under 
debate. Since the binding sites of the translocon to L23 and L35 are overlapping with 
the ribosomal binding sites for SRP, a strictly guided handover is possible, where SRP 
is stepwise exchanged for the translocon. A simplified representation of the targeting 
process is shown in Figure 3 C. The signal sequence has now engaged with the Sec61 
translocon, anchoring the nascent chain in the ER membrane and translation continues 





Figure 3: A Schematic representation of yeast and mammalian SRP. B Localisation of mammalian SRP on a 
translating ribosome. SRP54 is interacting with the ribosomal proteins L23 and L35, near the exit site, thus mainly 
interaction with the 60S subunit. The Alu-domain stretches to the interface between 60S and 40S, where the binding 
site of the elongation factor is located. C Co-translational targeting of the RNC complex. The signal sequence (green) 
is recognized by SRP, resulting in elongation arrest. Afterwards, the the complex is targeted to the SR, which is 
located on the ER membrane. How unloading of the RNC-SRP-SR complex to the translocon works is still under 
discussion. Upon unloading, hydrolysis of the active GTPases SR and SRP leads to dissociation of the proteins from 















1.3. Post-Translational Targeting and Translocation into the ER 
 
 
For efficient post-translational sorting via the appropriate targeting route proteins have 
specific labels, either sequential or structural, which destine them for the correct 
targeting machinery. Post-translational targeting and translocation into the endoplasmic 
reticulum was well characterized in Saccharomyces cerevisiae. The hydrophobicity of 
post-translational signal sequences is reduced, compared to co-translational signal 
sequences. Thus, SRP most likely fails to capture the signal sequence, resulting in a 
protein that is fully synthesized into the cytosol (Ng et al., 1996; Zheng and Gierasch, 
1996). To avoid aggregation in the wrong compartment, Hsp40/Hsp70 chaperones bind 
to the protein, keeping the protein in an unfolded, translocation-competent 
conformation (Ngosuwan et al., 2003). How post-translational substrates are targeted 
to the endoplasmic reticulum is not fully understood, however it is known that Sec61 
and the subcomplex Sec62-Sec63-Sec71-Sec72 are required for efficient targeting 
(Deshaies et al., 1991; Panzner et al., 1995). The Hsp70-chaperone Ssa1 was proven to 
chaperone post-translational substrates, while the Hsp40-chaperone Ydj1 acts as a co-
chaperone for Ssa, probably guiding it to the membrane (Becker et al., 1996). Lately, it 
was also shown that Ssa1 interacts with the ER-membrane associated Sec72, thus it is 
also likely that targeting to the translocon is mediated through Sec72 (Tripathi et al., 
2017). Once the substrate has somehow engaged with the translocon and a part of the 
polypeptide reaches the ER lumen, the luminal chaperone Kar2p acts as a molecular 
ratchet to translocate the polypeptide into the ER lumen (Matlack et al., 1999). Kar2p 
is recruited to the ER lumen via the J-domain of the co-chaperone Sec63 (Misselwitz 
et al., 1999). While Kar2p is an ATPase, the nucleotide-exhange factors Sil1 and 
GRP170 ensure exchanging of ADP with ATP (Behnke et al., 2015; Tyson and Stirling, 
2000). A simplified scheme of post-translational translocation is shown in Figure 4 

















Figure 4: Post-translational translocation in eukaryotes. Cytosolic chaperones prevent aggregation of the protein 
and prime it to the ER membrane, where the signal sequence engages with Sec61, mediated by the Sec62-Sec63 
complex (1). As soon as the polypeptide chain emerges from the luminal site of the translocon tunnel BiP (Kar2p) 
acts as a molecular ratchet to provide the vectorial force in order to translocate the polypeptide into the luminal 
side of the endoplasmic reticulum (2-4) (Park and Rapoport, 2012). 
 
A fraction of membrane proteins is also integrated via a different mechanism that 
involves the proteins SND1, SND2 and SND3 (SRP-independent targeting). The 
mechanisms, regarding targeting and integration are not well understood. SND1 is 
believed to be cytosolic, ribosome-bound and thus may be responsible for the initial 
recognition of the signal sequence, which was found to be located more in the center of 
the synthesized proteins. SND2 and SND3 are membrane proteins which might 
associate with Sec62-Sec63, thus they might act as a receptor for cargo-carrying SND1. 
It was also shown that the SND-pathway not only exclusively directs SND-dependent 
proteins to the ER, but also acts as a rescue pathway, when proteins fail to be captured 
by SRP or the GET-pathway (Aviram et al., 2016).  
 
Not all proteins have N-terminal signal sequences. Some proteins are also targeted to 
the endoplasmic reticulum by a C-terminal signal sequence, via the so-called GET-
mediated tail-anchored protein-insertion pathway (Stefanovic and Hegde, 2007). This 
pathway involves a different targeting and translocation machinery that is acting 
independent from Sec61. The mechanism of the GET pathway in yeast is visualized in 
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Figure 5. Since the signal sequence for insertion via the GET pathway is C-terminal, 
targeting cannot occur co-translationally. Instead, the newly synthesized proteins are 
captured by the carboxy-terminal binding domain of Sgt2, which is part of a pre-
targeting complex (Sgt2-Get4p-Get5p in yeast, Bag6-TRC35-Ubl4A in mammals) 
(Wang et al., 2010). In a subsequent step, the pretargeting complex loads its cargo onto 
Get3, a homodimeric ATPase, which transiently interacts with Get4 (Chartron et al., 
2010). How transfer of the TA protein onto Get3 is facilitated is still under debate. It is 
proposed that the TA protein is transferred from Sgt2 to ADP-Get3, since the ADP-
form of Get3 provides a hydrophobic grove for substrate binding (Mateja et al., 2009; 
Wereszczynski and McCammon, 2012). Interestingly, the TA binding domain (TABD) 
of Get3 shows similarity to the M-domain of SRP54, being rich in methionine and 
hydrophobic amino acids. The Get3-TA complex is further targeted to Get1-Get2, 
which are located on the endoplasmic reticulum membrane (Schuldiner et al., 2008). In 
Get2, long unstructured amino-terminal tails, on whose ends are short stretches of 
alpha-helices, capture Get3-TA, due to electrostatic interactions via a positively 
charged sequence in the Get2-tail and a negatively charged surface patch on Get3 
(Mariappan et al., 2011; Stefer et al., 2011). After Get3 has been tethered to Get2, 
cytosolic coiled-coil domains of Get1 dock to Get3-TA, facilitating opening of the 
complex, and releasing of the TA protein (Kubota et al., 2012). How the TA protein 
inserts into the membrane is not well understood. The insertion step could either be 
spontaneous, or facilitated by Get1/2. An insertion mechanism that mimics the substrate 
tansport mechanism of ATP-binding cassette (ABC) transporters also was proposed 
(Denic, 2012).  
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Figure 5: Illustration of the GET pathway in yeast. As soon as the signal of a TA protein emerges from the ribosome 
exit tunnel Sgt2 from the pretargeting complex binds to the TA domain. ATP-Get3 transiently associates with the 
loaded pretargeting complex, where the cargo is transferred to Get3 upon ATP hydrolysis (1). Loaded ADP-Get3 is 
targeted to the ER membrane via interacting with long N-terminal unstructured loops of Get2 (2). Docking to the 
membrane occurs via interacting with the coiled-coil domains of Get1 (3). This interacting leads to unloading of 
ADP-Get3 and the TA protein is somehow inserted into the membrane (4). After unloading Get3 dissociates from 























1.4. Structural insights into the Sec61 translocon machinery 
 
 
Independent of the translational status of polypeptides, transport through and into the 
ER membrane  is in most cases facilitated by the Sec61 translocon pore.  The translocon 
is a multi-subunit membrane pore, whose overall structure is highly conserved within 
all domains of life (Park and Rapoport, 2012). The first structure of a translocon (from 
Methanococcus jannaschii) was published in 2004 (Van den Berg et al., 2004).  
The core translocon machinery is a heterotrimeric complex, consisting of Sec61a, 
Sec61b and Sec61g (Sec61p, Sbh1p and Sss1 in yeast, SecY, SecE and SecG in 
bacteria). Sec61 is a multi-spanning membrane protein, consisting of 10 transmembrane 
domains (TM domains) (Figure 6). The translocon can be visualized as a membrane 
protein with two bundles of five TM domains each (TM domain 1-5 and TM domain 
6-10). The loop between TM domain 5 and 6 is acting as a hinge, connecting both 
halves. On the opposite side of the hinge, TM domain 2 and TM domain 7 are forming 
the lateral gate, which remains closed in the idle state. The idle translocon pore is 
obstructed by a so-called plug (also referred to as TM domain 2a). Mainly hydrophobic 
amino acids from TM domain 2,5,7 and 10 form a central constriction ring, which is 
narrowing the translocon channel, giving the pore an hourglass shape (Junne et al., 
2010). The translocon is placed asymmetrically in the ER membrane, with the 
constriction ring located more on the cytosolic site of the membrane (Demirci et al., 
2013). In eukaryotes, the nonessential Sec61b is a tail-anchored membrane protein, 
which only loosely contacts the a-subunit of Sec61. Sec61g is a tail-anchored, clamp-
like membrane protein. It has a long curved TM domain and is oriented diagonally in 
the membrane, thus contacting both halves of Sec61a (Rapoport et al., 2017).  Although 
it has been shown that yeast Sec61g is required for efficient translocation in yeast, the 
exact mechanism still remains elusive (Wilkinson et al., 2010).  
Electron microscopy and crystallization studies revealed that upon binding of the 
ribosome on loop 8 the translocon undergoes a conformational change, unplugging the 
pore and opening the lateral gate to the ER bilayer (Raden et al., 2000). However, the 




Figure 6: Crystal strucute of the idle SecY translocon channel from Methanococcus jannaschii. Visualized on the 
left is a view onto the translocon from the cytosolic side. The right shows the translocon from the lateral side. The 
two halves of the translocon are shown in red and blue. The b-subunit is shown in purple, the g-subunit is depicted 
in beige. The plug, which is sealing the pore, is shown in yellow (Rapoport et al., 2017).  
 
In order to modulate efficient protein translocation, additional proteins form transient 
complexes with the translocon. The requirements, mechanisms and specificities of 
these complexes are organism-dependent and still under debate. Many auxiliary 
proteins lack detailed structural studies, thus their contact sites, interactions and 
conformational behavior upon translocation often can only be speculated upon. 
The subcomplex Sec62-Sec63-Sec71-Sec72 is of high importance. The essential Sec62 
is a two TM domain membrane protein, contacting Sec61 near the lateral gate. Sec62 
and the essential three-TM domain containing membrane protein Sec63 interact via 
their oppositely charged N- and C-terminal cytosolic tails (Harada et al., 2011). Even 
though earlier studies proposed that Sec62-Sec63 is especially required for post-
translational translocation, recent findings demonstrated that a lack of Sec62-Sec63 
results in translocation- and integration-deficiency also for co-translational 
translocation and for membrane protein topogenesis regulation (Jung et al., 2014). 
Sec63 can be characterized as a co-chaperone, recruiting BiP (Kar2p in yeast) to the 
translocon via its J-domain (Misselwitz et al., 1999). BiP is binding to the nascent chain 
upon ATP hydrolysis and facilitates translocation into the ER lumen by acting as a 
molecular ratchet and by preventing backsliding of the nascent chain (Matlack et al., 
1999). Since BiP belongs to the ATPase family of chaperones nucleotide exchange 
factors are required to keep BiP in a functional state (Behnke et al., 2015). The non-
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essential Sec71 and Sec72 have been proposed to be important for correct membrane 
protein insertion (Green et al., 1992). Structural studies revealed that the cytosolic 
chaperone Ssa1 and the ribosome-bound chaperone Ssb1  interact with Sec72, 
proposing a recruiting mechanism for post-translationally translocated nascent chains 
to the translocon via Sec72 (Tripathi et al., 2017).  
 
The translocation process is often accompanied by several modification processes, like 
the cleavage of the signal sequence by the signal peptidase or the glycosylation of the 
polypeptide chain by oligosaccharyltransferase. For a detailed description of the signal 
peptidase see chapter 4. 
 
The yeast oligosaccharyltransferase (OST) is a nine subunit complex (Ost1p, Ost2p, 
Ost3p, Ost4p, Ost5p, Ost6p, Stt3p, Swp1p and Wbp1p) that transfers dolichol-linked 
sugar Glc3Man9GlcNAc2 on the Asparagine (Asn)-reside of the sequence Asn-X-
Ser/Thr, with X being every amino acid except proline (Tai and Imperiali, 2001). The 
function of the subunits is not well understood, however, it was shown that Ost1p, 
Ost2p, Stt3p, Swp1p and Wbp1p are essential. The subunit SST3p contains the active 
site (Karaoglu et al., 1997).  
TRAM (Translocating-chain associated protein) is a membrane protein with eight TM 
domains, which is involved into the translocation and integration of some proteins. It 
was shown that TRAM associates with the translocon and helps less hydrophobic TM 
domains to integrate into the membrane (Do et al., 1996; Görlich and Rapoport, 1993; 
Görlich et al., 1992).   
 
TRAP (Translocon associated protein) is a hetero-tetrameric complex that binds 
directly to Sec61 and OST. It was shown that TRAP somehow accelerates the 
translocation of some substrates and it might also participate in the topogenesis of 
membrane proteins, with focus on moderating the positive-inside rule. However, the 
exact function of TRAP is still unknown (Sommer et al., 2013).  
 
Recently, it was found that the membrane-bound metalloprotease Ste24 acts as a 
safeguard of protein translocation, clearing clogged translocons by cleaving SRP-
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independent membrane proteins which are stuck in the translocon due to misfolding on 
the cytosolic side. The exact mechanism is still unknown (Ast et al., 2016).  
 




Correctly folded proteins are of high importance for the cell, since only functional 
proteins can fulfill their anticipated function. To ensure that proteins that have reached 
the endoplasmic reticulum are in a correctly folded conformation, the cell has 
developed a quality control mechanism, which tests the newly synthesized proteins on 
their proper folding and send proteins that fail to fold for degradation via the 
endoplasmic reticulum associated degradation (ERAD) pathway. To ensure proper 
folding, the endoplasmic reticulum contains various chaperones, like protein disulfide 
isomerases (PDI), which catalyze disulfide-bond formation, peptide prolyl isomerases, 
which catalyze the isomerization of peptidyl proline bonds between cis and trans, and 
several chaperones from the Hsp40, Hsp70, Hsp90 and Hsp100 family (Ellgaard and 
Helenius, 2003). Generally, Hsp70 and Hsp90 chaperones belong to the family of 
ATPases and bind to not-yet correctly folded proteins. Normally, hydrophobic 
segments of proteins are located in the core of a folded protein, however in misfolded 
proteins these hydrophobic sequences are exposed to the aqueous environment, which 
is recognized by chaperones.  
The process of folding is further monitored by the calnexin/calreticulin-cycle via an 
Asn-linked glycosylation system. The OST complex transfers co-translocationally a 
Glc3Man9GlcNAc2 branched glycan on Asparagin-residues of the consensus sequence 
Asn-X-Ser/Thr (X is not proline) (Kornfeld and Kornfeld, 1985). After glycosylation, 
the glycan structure is changed by several ER resident glycosidases. First, a-
glucosidase I cleaves the terminal a-1,2-linked glucose, followed by cleavage of the 
now terminal a-1,3-linked glucose by a-glucosidase II (Trombetta et al., 1996). At this 
point, the calnexin/calreticulin cycle starts to chaperone the folding process. Calnexin 
and calreticulin are both chaperones of the lectin family, having calcium-ions bound in 
their globular domains near the carbohydrate binding site, which stabilizes the binding. 
The N-termini of both proteins together form a single carbohydrate binding-site which 
has high affinity to monoglucosylated glycans (Michalak et al., 2009; Schrag et al., 
	 23	
2001). Both chaperones contain a central proline-rich domain (P-Domain) that 
transiently interacts with either ERp57 (a protein disulfide isomerase) or cyclophilin B 
(CyB, a peptidyl-prolyl isomerase), which in turn can assist in proper folding of the 
substrates (Kozlov et al., 2010; Oliver et al., 1997). If the substrate does not manage to 
fold correctly, a-glucosidase II will also cleave the last a-1,3-linked glucose, leaving 
an unglucosylated glycan on the substrate (Stigliano et al., 2011). In principle, the 
substrate can now follow three pathways: if the protein is folded correctly it will be 
released, its glycan further trimmed by ER mannosidases, and may be exported from 
the ER. If the protein is still misfolded, it is either re-monoglucosylated by UDP-
glc:glycoprotein glucosyltransferase I (UGGT1), resulting in reinitiation of the 
calnexin/calreticulin-binding, or it can in addition undergo cleavages by mannosidases 
that direct the misfolded protein to the ERAD pathway. In general, a protein can 
undergo several calnexin/calreticulin cycles until it is either properly folded or sent to 
degradation (Quan et al., 2008; Taylor et al., 2004). 
 
The ERAD pathway is crucial for cells homeostasis, sending misfolded proteins for 
degradation into the cytosol, where the proteins are finally degraded by the ubiquitin-
proteasome system. The ERAD pathway through Hrd1 has been extensively studied in 
yeast and the results can also be extrapolated to mammals (Carvalho et al., 2006) The 
machinery involves a cascade of several proteins in different compartments. Since 
misfolded proteins can be very diverse, with unfolded domains either in the ER lumen, 
the ER membrane, or in the cytosol, several pathways emerged to ensure specific 
degradation: Substrates undergoing the ERAD-L pathway have misfolded domains in 
the ER lumen, while  ERAD-M substrates have misfolded intermembrane domains. 
Both substrates are degraded via the Hrd1-E3-Ligase. ERAD-C substrate present un- 
or misfolded parts to the cytosol and are degraded via the Doa10-E3-ligase (Carvalho 
et al., 2006). It was also proposed that retrotranslocation can occur via the Sec61 
channel, however direct involvement of Sec61 is still under debate (Römisch, 2017). 
A schematic representation of the ER quality control system is shown in Figure 7. A 
misfolded protein is prone for degradation after mannosidases have trimmed the N-
linked glycans, generating a terminal a-1,6-linked mannose residue which is 
recognized by the lectin Yos9p (Clerc et al., 2009; Xie et al., 2009). Probably Kar2p 
recruits the misfolded Yos9p-bound substrate to Hrd3p, a membrane protein that 
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additionally binds to unfolded regions of the substrate, activating it for degradation 
(Plemper et al., 1997). Hrd3p transfers the misfolded protein to the membrane-bound 
Hrd1 dimer, which is forming a pore and is facilitating retrotranslocation of the 
misfolded protein back into the cytosol, assisted by Der1. ERAD-M substrates might 
enter the Hrd1 pore laterally (Sato et al., 2009). Once the substrates enter the cytosol 
they are polyubiquitinated on lysine residues via Hrd1p, which recruits the ubiquitin-
carrier Ubc7, an E2-konjugating enzyme. The retrotranslocated, polyubiquinated 
substrate is carried to the proteasome for degradation by cytosolic chaperones, like 
Bag6 (Ruggiano et al., 2014). 
 
 
Figure 7: The ER quality control system (Araki and Nagata, 2011). A Co-translational translocation of newly 
synthesized proteins into the endoplasmic reticulum. Upon entering of the nascent chain into the ER lumen the OST 
complex catalyzes the N-glycosylation of the polypeptide B Posttranslational translocation of tail-anchored proteins 
into the ER membrane via the GET pathway. C The calnexin/calreticulin cycle. The calnexin/calreticulin cycle 
recognizes N-glycans and test them on proper folding. D ER exit for correctly folded proteins. E The ERAD pathway 
for misfolded proteins. If a protein does not manage to fold during the calnexin/calreticulin cycle the N-glycans are 
trimmed by mannosidases, followed by retrotranslocation into the cytosol via an E3-ligase complex. The protein is 
then degraded via the ubiquitin proteasome pathway.   
 
If the load of misfolded proteins in the endoplasmic reticulum starts to increase and 
reaches a certain threshold level, the cell starts to react by the well conserved unfolded 
protein response (UPR). The UPR tries to meet the ER stress by upregulating the ER-
resident chaperone synthesis and at the same time attenuate translation. If the UPR does 
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not manage to lower the level of misfolded proteins it aims towards apoptosis (Shore et 
al., 2011). In general, three ER resident membrane proteins are ER stress sensors and 
signal to the cytosol or to the nucleus for countermeasures: PERK, Ire1 and ATF6. 
Among the many functions of BiP one is also the blocking of the three ER stress 
sensors, by binding to these receptors. Only when the threshold of misfolded proteins 
reaches a certain level, BiP disassembles from the ER stress sensors to bind to 
hydrophobic patches of the misfolded proteins. This unbinding activates the sensors.  
Upon unbinding of BiP, PERK homodimerizes, followed by autophosphorylation of its 
kinase domain, which in turn induces phosphorylation and thus inactivation of the 
elF2a, a transcription factor. This leads to reduced translation of new proteins, thus 
helping the ER to clear its lumen from misfolded proteins by ERAD (Kebache et al., 
2004; Raven et al., 2008). 
The IRE1 pathway shows similarity to PERK. Dimerization of IRE1 happens after 
unbinding of BiP, followed by autophosphorylation. This phosphorylation activates the 
endoribonuclease activity of IRE1, which cleaves the XBP1-mRNA, resulting in a 
frameshift variant of XBP1 that acts as a transcriptional factor to modulate gene 
expression of chaperone and ERAD genes (Hetz and Glimcher, 2009).  
ATF6 exits the endoplasmic reticulum after BiP dissociates from its N-terminus by 
vesicular transport to the Golgi apparatus. Once at the Golgi apparatus, ATF6 is cleaved 
two times by the intramembrane proteases S1P and S2P. The soluble cytosolic ATF6-
domain is trafficked into the nucleus, where it increases transcription of genes, 
encoding for chaperones, like BiP or PDIs (Chen et al., 2002; Shen et al., 2002; Yoshida 












1.6. The biogenesis of membrane proteins at the Sec61 translocon 
 
 
The biological membranes that separate different compartments in a cell mainly consist 
of phospholipids, sphingolipids, sterols and membrane proteins (Harayama and 
Riezman, 2018). One of the major characteristics of the lipid bilayer membrane is the 
hydrophobicity of the acyl chains, which are oriented towards the membrane core, 
while the polar head group is exposed to the hydrophilic environment of the cell. The 
thickness of the hydrophobic core of a membrane generally is around 30 Å (Watson, 
2015). While an organelle provides a separate environment with specialized functions, 
membrane proteins are crucial for the inter- and intracellular communication between 
these different enclosed cell compartments. About 30% of all proteins are membrane 
proteins (Krogh et al., 2001). Generally, two major types of membrane proteins can be 
discriminated: a-helical membrane bundle proteins and b-barrel membrane proteins. 
The latter are only found in the outer membrane of mitochondria or chloroplasts. The 
topologies of mature helix-bundle proteins can be quite divers, not only when it comes 
to stoichiometry, but also in number and orientation of the TM domains. Their cytosolic 
and luminal loops can bear several interaction motifs, which are often required for 
intracellular communication. Despite this heterogeneity, membrane proteins can 
basically be subdivided into only three classes ((Higy et al., 2004), Figure 8 A). This 
simple model only considers the orientation of the first TM domain. In secreted proteins 
the signal sequence is cleaved of by the signal peptidase (a). In single-spanning 
membrane proteins the signal sequence is either a part of the mature protein, or it is also 
cleaved of and the protein is anchored in the membrane by an internal TM domain (b, 
Type I). Proteins with non-cleaved signal sequences can attain two topologies: while a 
normal signal-anchor results in a protein with N(in)-C(out) topology (c, Type II), a 
reversed signal-anchor leads to a protein with N(out)-C(in)-topology (d, Type III).  
Multispanning membrane proteins basically can be described by combination of the 
abovementioned 4 elements (e-g). A signal-anchor domain in N(in)-C(out) orientation 
is followed by a stop-transfer domain (N(out)-C(in)), which is succeeded by a re-








Figure 8: A Membrane proteins can be classified into several classes. a Cleavable signals (red rectangle with 
black arrowhead) results in a soluble protein. b Cleavable signal with an additional transmembrane domain results 
in a Type I membrane protein in N(out)-C(in)-orientation. c Uncleavable signal-anchor, resulting in a Type II 
membrane protein in N(in)-C(out)-orientation. d Reversed signal-anchor (blue rectangle), resulting in a Type III 
membrane protein in N(out)-C(in)-orientation. e – f Examples for multispanning membrane protein topologies. 
Adapted from (Higy et al., 2004). B The three integration steps for TM domains. The red TM domain is a signal-
anchor domain. The stop-transfer domain (orange) moves through the translocon pore and exits the translocon 
through the lateral gate, if it overcomes the required hydrophobicity threshold.  The re-integration domain (purple) 
is located on the cytosolic site. How it enters the translocon pore is still under debate. 
 
In contrast, a reversed signal-anchor (N(in)-C(out)) is followed by a re-integration 
domain, thus, the third TM domain is a stop-transfer domain.  The overall 
understanding of the mechanisms leading to efficient integration is based mainly on the 
concept of sequence autonomous, hydrophobicity-dependent integration: Independent 
of its sequence context, a domain integrates into the ER membrane if it overcomes a 
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certain hydrophobicity threshold, otherwise it will either be translocated into the ER 
lumen (for ST-TM domains) or it will remain in the cytosol (for RI-TM domains). Thus, 
hydrophobicity was soon known to be the major driving force for membrane protein 
integration. Several studies engaged the question how much hydrophobicity is required 
for a domain to efficiently integrate into a membrane. To do so, hydrophobicity scales 
were created that determine the contribution of each amino acid to the overall 
hydrophobicity of a domain (MacCallum and Tieleman, 2011).  
 
A first and simple hydrophobicity scale was proposed by Radzicka and Wolfenden. 
This scale is based mainly on the partitioning of single amino acids between an aqueous 
phase and cyclohexane (Wolfenden, 2007). The hydrophobicity scale developed by 
Wimley and White is based on a similar approach, however using a pentapeptide (Ace-
WLXLL, X=each amino acid) and measure the equilibration of each of these 
pentapeptides between water and 1-octanol (Wimley and White, 1996).  
(Hessa et al., 2005) established a ‘biological hydrophobicity scale’, where the 
contribution of each amino acid to the integration threshold of a domain into the lipid 
bilayer was determined. To do so, a model protein derived from leader peptidase (Lep) 
was created, containing a mildly hydrophobic segment (H-segment) in stop-transfer 
orientation that consists of 19 alanine host residues. The H-segments hydrophobicity 
was modulated by replacing individual alanines with one of the other 19 amino acids. 
Insertion of the domain into the lipid bilayer of dog pancreas-derived rough microsomes 
was determined from the glycosylation pattern. The apparent free energy for each 
amino acid was determined similarly to the free energy calculations of the other 
hydrophobicity scales. A comparison of the different hydrophobicity scales is shown in 




Figure 9: A Schematic representation of the equilibration principles behind the hydrophobicity scales from 
Razdika, Wimley and Hessa. Adapted from (MacCallum and Tieleman, 2011) B Biological hydrophobicity scale 
from Hessa et al. (2005). The one letter code for each amino acid is shown together with the Δ"!"" values.    
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Besides the hydrophobicity of a domain several other properties of a polypeptide were 
identified that influence topogenesis. Back in 1986 Gunnar von Heijne described a 
phenomenon called “positive-inside rule” by observing a charge imbalance in signal 
sequences of proteins in the bacterial inner membrane (Heijne, 1986). This rule was 
later further verified in eukaryotes (Hartmann et al., 1989). It states that the orientation 
of a signal sequence in the membrane is dependent on the difference of flanking 
charges: positively-charged regions are oriented to the cytosol, while negatively 
charged regions are oriented to the outside (in bacteria) or to the ER lumen (in 
eukaryotes). These findings provided a first tool to predict the topology of membrane 
proteins and the linear-insertion model arose from these results: the first TM domain 
orients itself in accordance with the positive-inside rule, thus fixing the orientation of 
all following TM domains. It was shown that the topology of Type III membrane 
proteins can be inverted by exchanging the flanking charges (Beltzer et al., 1991). The 
positive-inside rule applies to some extend also to multispanning membrane proteins 
(Heijne, 2006). The positively charged amino acids lysine and arginine are more 
commonly found on the cytosolic side, while on the extracellular site their occurrence 
is significantly reduced. 
This model was soon shown to be insufficient to explain the topology of some 
membrane proteins. It was  revealed that folding of the N-terminal part of the sequence 
can occur co-translationally when exposed to the cytosol, thus preventing insertion of 
the folded N-terminal domain into the translocon, resulting in a N(in)-C(out)-topology, 
regardless of the charge distribution (Denzer et al., 1995). Futhermore, N-terminal 
signal sequences  enter the translocon pore in a head-first orientation and invert co-
translationally (Devaraneni et al., 2011; Goder and Spiess, 2003). Another finding 
concerning the orientation of the signal sequence was that length and hydrophobicity 
of the h-region is affecting the topology: a long hydrophobic h-region favor 
translocation of the N-terminus, while a short h-region translocates the C-terminus into 
the ER lumen (Wahlberg and Spiess, 1997).  
Interestingly, signal-anchors do not necessarily have to be located near the N-terminus, 
but can also be localized in the internal part of a protein sequence. It was demonstrated 
that long N-terminal hydrophilic sequences do not affect protein targeting to the 
translocon and promote translocation of the C-terminus independent of the signal-
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anchor’s hydrophobicity (Kocik et al., 2012). Thus, for internal signal-anchors the 
signal sequence does not enter head-first, but orient themselves before pore-insertion.   
 
While for single-spanning membrane proteins the final topology is already not easy to 
predict, due to the abovementioned intrinsic properties, the complexity increases even 
more for multispanning membrane proteins, where at least one additional 
transmembrane domain is complicating the translocation and integration mechanism.  
The hypothesis that hydrophobicity of a potential transmembrane domain is the main 
driving force for membrane integration has been further challenged by examining the 
amino acid composition of several natural transmembrane domains. Especially TM 
domains from ion channels and aqueous pores were identified to have a low overall 
hydrophobicity, thus prediction programs often do not recognize these TM domains 
(De Marothy and Elofsson, 2015). To efficiently integrate charged TM domains into 
the membrane the charged residues of arginine and lysine can `snorkel` into the 
hydrophilic environment of the lipid’s polar head groups, thus minimizing the energetic 
cost of integrating a charged residue into the lipid bilayer (Li et al., 2013). Another 
possibility to overcome the hydrophobicity threshold required for efficient integration 
is cooperative membrane integration. In this model mildly hydrophobic TM domains 
do not integrate alone, but together with neighboring TM domains (Hedin et al., 2010).  
Lately, it was shown by that the integration of a potential stop-transfer TM domain is 
in general not only dependent on the hydrophobicity of the domain, but also on a 
sequence up to 100 amino acids downstream of the TM segment (Junne and Spiess, 
2017). These findings suggest that topogenesis is a far more complex process, which is 
influenced not only by hydrophobicity, but also by intrinsic determinants in the 




Part I: Biogenesis of multispanning membrane proteins: 
membrane integration of N(in)-C(out) transmembrane 





The topogenesis of membrane proteins in the lipid bilayer of the ER is of high 
complexity. The definition of a biological hydrophobicity scale suggested a rather 
simple mechanism based on sequence-autonomous, mainly hydrophobicity-dependent 
equilibration between the membrane and aqueous compartments. Previous studies (in 
particular Junne and Spiess, 2017) already indicated that sequences outside of potential 
transmembrane domains may affect transmembrane domain integration. 
 
The focus of this thesis was to dissect the requirements and mechanisms that drive re-
integration. To address this questions we mainly investigated the hydrophobicity 
threshold of a potential transmembrane domain in N(in)-C(out)-orientation for  
integration into the ER membrane. We discovered that this threshold critically depends 
on the properties of the preceding cytosolic polypeptide sequence. By changing this 
loop sequence, we investigated the features facilitating or inhibiting transmembrane re-







3.1. The hydrophobicity threshold for re-integration is modulated 
by the preceding cytoplasmic loop length. 
  
For translocation and integration studies, we have used a model protein derived from 
yeast dipeptidyl-aminopeptidase B (DPAPB or DAP2), a SRP-dependent type II 
membrane protein. The integration efficiency of generic stop-transfer domains was 
analyzed by replacing residues 170-378 with a mildly hydrophobic domain (H-
segment), flanked by GGPG/GPGG hydrophilic helix-breaking insulators. The host 
sequence of the H-segment consists of 19 alanines. To modulate hydrophobicity, 
leucine guest residues of variable numbers (0-19) were replacing host alanines (for a 
list of all the H-segments used in this work see Appendix B). Since a major part of the 
native protein was deleted and additional residues were added to the protein, the 
resulting construct is unable to obtain a native fold (which according to the prevailing 
model of transmembrane integration is no concern). The construction pathway from the 
native DPAPB to our model protein is shown in Figure 10 A. To discriminate between 
the translocated (N) and integrated (I) form, glycosylation sites present in the protein 
made it possible to dissect the topology by analyzing the glycosylation pattern (Figure 
10 B). Due to the non-native nature of the model protein, degradation via ERAD might 
influence the outcome of the experiment when looking at steady-state by western blot. 
To avoid this problem radiolabeling was used to examine the non-equilibrium ratio of 
the two topologies immediately after synthesis.  The hydrophobicity threshold was 
determined after short pulse labeling with [35S]methionine for 5 min, followed by 
immunoprecipitation against a C-terminal HA-Tag that is present in all model proteins, 
gel electrophoresis, and autoradiography. The hydrophobicity threshold is by definition 
the amount of leucines that are required in an H-segment for more than 50% membrane 
integration.  For ST-DP this value was found to correspond to ~4 leucines in the H-
segment by Junne et al. (2010) and Demirci et al. (2013) (Figure 10 C and D, left side). 
This is generally interpreted as the result of thermodynamic equilibration of the stop-
transfer H-segment, between translocon pore and the lipid membrane after the segment 




Figure 10: A The cloning pathway for ST-DP and RI-DP. The signal-anchor domain is marked in red, ST-domains 
are orange, re-integration domains violet. The Lep-constructs from Lundin et al. are shown to visualize the difference 
between the two model proteins. The reverse signal-anchor of RI-Lep is visualized with a red/white pattern. 
Glycosylation sites are indicated with an Y. B Schematic representation of the topologies for ST-DP and RI-DP. As 
indicated with a Y, fully integrated ST-DP has four out of seven glycosylation sites glycosylated. On the contrary, 
for RI-DP the fully integrated form has seven glycosylated sites in the lumen, while partial glycosylation only occurs 
for the partially inserted RI-DP C Autoradiographs for ST-DP (Demirci et al., 2013)and RI-DP. Wild-Type yeast 
cell are producing the model proteins with 0 – 6 and 0 – 9, 11, 15, 19 leucines in the H-segment. The different 
glycosylation patterns lead to a difference in molecular weight, which is visualized after metabolic labeling with 
[35S]methionine, immunoprecipitation and SDS-gel electrophoresis. The band related to an integrated H-segment is 
marked in both gels with an I (Integrated). N stands for non-integrated for the re-integration constructs. Concerning 
the ST-DP, T stands for translocated. U marks the unglycosilated band in both model proteins. The asterisk indicates 
bands of a truncated version of the protein, produced due to internal initiation (see Appendix A) D  Quantitation of 
the experiments are shown in C. For the re-integration graph the value determined by Lundin et. al (2008) is shown 




In contrast, the mechanism of re-integration is more complicated. The re-integration 
domain is synthesized into the cytosolic vestibule between the ribosome and the 
translocon, where it needs to engage with the translocon to initiate membrane 
integration and C-terminal translocation similar to a signal-anchor sequence, or to 
follow the preceding loop into the cytosol (see Figure 8 B).  
Lundin et al. (2008) were the first to analyze this re-integration step using a Leader 
peptidase (Lep)-derived model protein in yeast and found the molecular code for these 
N(in)-C(out) transmembrane sequences to parallel that for stop-transfer integration 
(Lundin et al., 2008). Surprisingly, the integration threshold was shifted to a lower 
hydrophobicity of only ~2 leucines for re-integration, compared to ~3 leucines for stop-
transfer with their Lep-derived model protein (Hessa et al., 2005).  
 
To determine the hydrophobicity threshold required for efficient re-integration in our 
system, a RI-DP model protein was created by cloning the DPAPB codons 1 – 146 in 
front of ST-DP, resulting in a protein with an H-segment for potential integration in an 
N(in)-C(out) topology. The integrated topology of the H-segment (I) thus has seven 
sites glycosylated, while for the non-integrated, cytosolic topology (N) glycosylation 
only occurs on the four sites in the loop connecting the SA domain with the ST domain. 
The RI-DP124 constructs were created with 0 – 9, 11,15, and 19 leucines in the H-
segment. The integrated band appeared with 5 leucines, becoming more prominent the 
more leucines were present in the H-segment. Interestingly, the re-integration 
efficiency reached a maximum at ~15 leucines with ~80% re-integration and decreased 
to ~60% for 19 leucines. The reduction of re-integration efficiency for strong 
hydrophobic H-segments could be seen in several construct series in this study. Upon 
digestion with endoglycosidase H (EndoH) the bands representing the glycosylated 
forms collapsed into the band representing the unglycosylated protein.  About 7 
leucines were required for 50% re-integration, in contrast to only 4 leucines for stop-
transfer integration. Notably, the bands in the re-integration constructs appeared as 
double bands. This indicates that glycosylation on one of the glycosylation sites in the 
front part of our model protein is not 100% efficient. However, this did not affect the 
general interpretation of the data, since the integration (I) band and non-integration (N) 
bands in the autoradiographs were still distinguishable. The lower band in Figure 10 
C, which is indicated by an asterisk is not an unglycosylated form of our model protein, 
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but represents a truncated form of our model protein which was expressed due to 
internal initiation of a methionine start codon (for details, see Appendix A).  
The discrepancy of the re-integration efficiencies of 2 leucines for RI-Lep vs. 7 leucines 
for RI-DP124 led us to the conclusion that re-integration efficiency is not only 
dependent on hydrophobicity, but may be influenced by additional determinants. Junne 
and Spiess (2017) already observed for stop-transfer integration that the hydrophobicity 
threshold is not only dependent on the number of leucines, but also on a sequence of up 
to 100 amino acids downstream of the H-segment . Thus, the concept of sequence-
autonomous, mainly hydrophobicity dependent integration may not be generally valid. 
Up- or downstream sequences may influence transmembrane integration efficiency. A 
comparison of the RI-Lep and the RI-DPAPB model proteins shows the following 
differences: RI-Lep consists of a reverse signal-anchor, a 37-amino acid linker, and a 
RI-H segment. RI-DP consists of a normal signal-anchor, a stop-transfer TM domain, 
a 124- amino acid linker, and a RI-H segment.   
 
To dissect, whether the differences in re-integration efficiency of the abovementioned 
two model proteins can be explained by the differences in linker length, four DPAPB 
construct series with shortened linker lengths were created. A former study showed that 
positively charged amino acids in the regions flanking the H-segment can influence its 
integration behavior (Lerch-Bader et al., 2008). To avoid different flanking regions the 
first 16 amino acids upstream of the H-segment were kept unchanged. The deletions 
were carried out via  PCR, reducing the linker lengths from 124 amino acids, to 96, 71, 





Figure 11: A Schematic representation of the model constructs, derived from DPAPB. They consist of a signal-
anchor (red rectangular), a stop-transfer domain (orange) and a RI-H segment (purple). Glycoslyation sites are 
indicated with a Y. The linker between ST-TM domain and RI-H was truncated, letting the first 16 amino acids 
untouched (strived sequence). B Autoradiographs of the constructs series shown in A. The glycosylation pattern of 
the  constructs was analyzed in yeast cells after pulse labeling with [35S]methionine, immunoprecipitation and SDS-
gel electrophoresis.The asterisk indicates bands of a truncated version of the protein, produced due to internal 
initiation (see Appendix A) C Quantitation of the autoradiographs. The re-integration efficiency increases for short 
linker lengths.  
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The results demonstrated a strong linker-length dependency, with an increased re-
integration efficiency for small linkers. The re-integration threshold in relation to the 
linker length is shown in Figure 12. 
 
 
Figure 12:The re-integration threshold plotted against the linker length for the RI-DP constructs. The value increases 
with growing linker length, thus re-integration efficiency declines. As comparison the re-integration threshold from 
Lundin et al. (2008) is shown as a blue rectangle. The re-integration threshold of the RI-Lep fits to the curve we 
obtained for the linker-length dependency.   
 
Upon reduction of the linker length, the hydrophobicity threshold decreased from 
initially 7 leucines for 124 amino acids to only 2 leucines for 19 amino acids. An 
exception was the construct DP96, which showed the highest hydrophobicity threshold 
(8 leucines) among the tested constructs, even though it is shorter than DP124. Only 
the construct series DP19 and DP46 showed a re-integration efficiency of 100% for 
more than 4 and 5 leucines, respectively. The abovementioned effect of inefficient 
integration for very hydrophobic H-segment (19 leucines) occurrd in all construct 
series, except RI-DP46.  
 
Even though an important observation of this experiment was the finding that re-
integration becomes more efficient for short linker lengths, re-integration efficiency 
and linker length cannot easily be correlated. The relation seemed to be true for RI-
DP19, RI-DP46 and RI-DP71, however, the construct series RI-DP96 was less efficient 
in re-integration, compared to RI-DP124. Moreover, the findings explain the results 
Lundin et al. (2008) obtained from their integration studies with RI-Lep, which has a 






























2.2 leucines. As can be seen in Figure 12 (blue rectangle) the hydrophobicity threshold 
for RI-Lep fited to the curve we obtained, providing evidence that the differences in re-
integration efficiency can be explained by the linker-length. 




The outcome of the abovementioned experiment demonstrated that the length of the 
cytosolic loop of RI-DP124 has a great influence on the re-integration efficiency of the 
RI-H segment. The results showed an overall tendency towards a high re-integration 
efficiency for small loops, while the re-integration of H-segments preceded by longer 
loops was less efficient. This length-dependency could have several reasons. Time is 
one of the most obvious factors influenced by the loop length: a shorter loop needs less 
time to be synthesized than a long linker. In yeast, the common translation speed is 3.0 
– 10 aa/s (Karpinets et al., 2006), hence the smallest linker (19 aa) needs 1.7 - 5.6 
seconds to be synthesized, compared to 12.4 - 41.3 seconds for the longest linker (124 
aa). During synthesis of the loop, the dynamics of the translocation system might 
change. It was shown that neighboring TM domains of multispanning membrane 
proteins show cooperativity: a TM domain which integrates into the lipid bilayer is for 
some time still localized near the Sec61 lateral gate, thus interactions with a following 
TM domain helps both domains to overcome the hydrophobicity threshold necessary 
for integration.  
An increased loop length which is always accompanied with an increased time passing 
until the RI-TM domain emerges from the ribosome exit tunnel, might lead to diffusion 
of the preceding stop-transfer TM domain into the cytosol, making it unable to aid in 
re-integration of the following RI-TM domain. According to this hypothesis, an 
increased time results in a decreased re-integration efficiency, since the RI-H segment 
has to integrate into the membrane without assistance of the previous ST-TM domain.  
To modulate time-dependency the translation speed was reduced by using 
cycloheximide (CHX), a known protein-synthesis inhibitor, which slows down 
translational elongation. The constructs RI-DP19-L3, RI-DP46-L3 and RI-DP124-L7 
were radiolabeled, supplemented with 0, 1 and 2 µg/ml cycloheximide, reducing the 
translation rate by 0, ~2, and ~4-fold, respectively. The outcome of the experiment is 




Figure 13: Slowing down of translation speed increased the re-integration efficiency A Autoradiographs of the 
constructs DP19-L3, DP45-L3, DP71-L3 and DP124-L7, supplemented with 0, 1 or 2 µg/ml CHX. The constructs 
were expressed in yeast and the glycosylation pattern (I = Fully integrated form, N = Partially integrated form) was 
analyzed after metabolic labeling as described in Figure 10. B Quantification of the re-integration efficiencies. Re-
integration efficiency increases upon treatment with CHX. 
 
Surprisingly, reduction of translation speed led to an increased re-integration efficiency 
for all constructs, which is in contrast to the scenario described above. Re-integration 
efficiency increased from 54% for 0 µg/ml CHX to 75% for DP46-L3, from 19% to 
45% for DP71-L3 and from 47% to 64% for DP124-L7.  
The result of these experiments disproved the hypothesis that the linker-length 
dependency observed in the previous chapter is caused by the time needed to synthesize 












The outcome of the linker length reduction assays performed in chapter 3.1 
demonstrated the importance of including the properties of the upstream sequence when 
estimating a RI-TM segment's integration efficiency. However, the reduction of the 
linker length alone did not provide an explanation for the effect, observed for the two 
construct series RI-DP124 and RI-DP96. To further analyze the underlying 
mechanisms, it was important to reconsider which variables are changed via linker 
length reduction, since the deletion of several amino acids in a given cytosolic loop 
does not only make it shorter, but also alters its intrinsic properties, including protein 
folding and affinity to chaperones.  
 
To minimize the side effects of folding and chaperone binding, the DPAPB-derived 
linker sequence was substituted with a generic glycine-serine repeat sequence that is 
highly flexible and water soluble, and unable to be recognized by chaperones. To 
directly compare the outcome of this experiment with the experiment performed in 3.1 
the linkers were chosen to have a similar length than the original DPAPB linker and its 
truncated derivatives. Linkers of 31, 53, 76, 99, and 122 amino acids consisting mainly 
only of glycine-serine repeats were created and cloned into RI-DP124, exchanging 
codons 196 – 321 with the abovementioned GS repeats. The GS repeat sequences are 







Figure 14: The non-folding GS repeat constructs integrate more efficiently than the original DP sequences. A The 
GS repeat sequences used as cytosolic loop. B The glycosylation pattern (I = Fully integrated, N = partially 
integrated, U = unglycosylated) was determined after metabolic labeling as described in Figure 10. C shows the re-
integration graphs of the GS-repeat constructs (solid line) and compares them to the DP linker constructs (dashed 
line). In the lower right graph the curves for all GS-repeat constructs are blotted.  
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The autoradiographs and the quantifications are shown in Figure 14 B and C. The 
quantifications compare the re-integration efficiency of the DPAPB natural sequence 
with the GS-repeat sequences. For the short linker lengths (DP17/GS31 and 
DP46/GS53), the differences between natural and generic linkers were not significant. 
However, the construct pairs DP71/GS76, DP96/GS99 and DP124/GS122 showed a 
significant difference in integration efficiency. In general GS sequences were more 
efficient and the length dependency was largely abolished. Figure 15 shows the re-
integration threshold for the GS-repeat constructs and correlates them to the linker 
length. For comparison the linker length dependency of the RI-DP constructs is shown.  
 
 
Figure 15: Comparison of the linker length dependency for RI-DP (green) and RI-GS (blue). The re-integration 
threshold is blotted against the linker length.  
 
A weak linker-length dependency was also observed for the GS-repeat constructs, 
spanning from 2.7 leucines for RI-GS31 to 4.4 leucines for RI-GS122. However, this 
effect was not as strong as for the native linker, where a range of 2 – 8 Leucines was 
observed. The result demonstrated that the apparent linker-length dependency for the 
natural sequences was not caused by the length reduction, but by changing other 
intrinsic features of the sequences. These differences only result in an altered re-
integration efficiency for loops longer than 50 amino acids. 
 
The GS repeat sequences were used to create cytosolic loops that are hydrophilic, 
flexible and do not fold. Such intrinsically disordered domains can also be found in 
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natural proteins. One example is nucleoporin, a protein which is involved in nuclear 
import (Peleg and Lim, 2010). To test if naturally unfolded (or disordered) domains 
behave similar to the generic GS repeat sequence, we replaced the GS sequence with a 
part of nucleoporin. We cloned codons 614 – 711 from yeast Nup1 (Uniprot entry: 
P20676) into RI-GS99 replacing the cytosolic loop by the Nup1 sequence to test how 
naturally intrinsically disordered domains influence the re-integration efficiency of a 
following re-integration TM domain. The result of this experiment is shown in Figure 
16. RI-Nup102 is compared to RI-GS99, which has a similar loop length.  
 
 
Figure 16: Analyzing the integration behavior of constructs with an intrinsically disordered domain in front of the 
H-segment. A Autoradiograph of the construct RI-Nup102 after expression of the construct in yeast and metabolic 
labeling as described in Figure 10.. B Quantification and comparison of RI- NUP102 (blue) with RI-GS99 (green). 
Both construct series are in a similar efficiency range.  
 
The hydrophobicity threshold for RI-Nup102 was found to be ~4.0 leucines and is very 
similar to the threshold for RI-GS99, which was ~3.5 leucines. Interestingly, the 
decrease in re-integration efficiency for H-segments with 19 leucines was not observed 
for RI-Nup102. 
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The similarity of the re-integration efficiencies of totally different amino acid sequences 
provided first evidence that naturally disordered domains in the cytosolic loop have an 































3.4. Polypeptide folding affects re-integration efficiency 
 
 
The outcome of the abovementioned experiments led us to the conclusion that the 
linker-length effect was mainly caused by the different conformational properties of the 
linker sequences. While GS-repeats and Nup102 are naturally disordered, the DP-
derived sequences are likely to form partial secondary structures. However, the loop 
sequences of the DP constructs were taken out of the context of the native protein (see 
Figure 11), so they are unable to attain a native fold. Instead they are likely to form 
molten globule intermediates.  
To analyze how domains with a defined structure affect the re-integration efficiency, 
we introduced wild-type zincfinger motifs and their folding-deficient counterparts into 
the cytosolic loop. The zincfinger motif consists of only 29 amino acids with the 
sequence KPYPCGLCNRCFTRRDLLIRHAQKIHSGN. Previous studies 
demonstrated that zinc fingers can already form in the ribosome exit tunnel (Nilsson et 
al., 2015b). The cysteine residues at position 5 and 8 are coordinating a zinc ion, 
together with the histidines at position 21 and 26 (marked in red). Upon mutation of the 
histidine at position 21 to a proline, zinc coordination is lost and the motif cannot fold 
into its native structure. Several constructs were created as shown in Table 1. 
Table 1: Schematic description of the zincfinger constructs used to analyze the effect of folding on re-integration 
Zf means zincfinger motif, while mZf corresponds to the mutated zincfinger motif..  
Construct Name Schematic cytosolic loop sequence  Total linker length 
RI-ZG61 LKGASS-(Zf)-GS-(SG)11-STS 61 aa 
RI-PG61 LKGASS-(mZf)-(SG)11-STS 61 aa 





For RI-ZG61/PG61 the position of the zincfinger motif is cloned on the N-terminal end 
of the cytosolic loop and is followed by the generic GS repeat sequence to ensure that 
the zincfinger motif has enough time to fold correctly and does not interact with other 
amino acids in the cytosolic loop. The constructs RI-4xZf103/4xPf103 were cloned to 
analyze how accumulations of several rapidly folding domains affect the re-integration 




Figure 17: Rapidly folding zincfinger domains influence the integration efficiency of RI-H segments. Wildtype 
zincfinger (blue)  motifs in front of the H-segment result in a higher re-integration efficiency compared to a mutated 
zincfinger (red) motif. GS repeat constructs with comparable loop lengths are shown in green A Autoradiographs 
and quantification of RI-ZG61 and RI-PG61. B Autoradiographs and Quantification of RI-4xZf103 and RI-4xPf103. 
The glycosylation pattern (I = Fully integrated form, N = partially integrated form, U = unglycosylated) was analyzed 
after expression of the constructs in yeast, followed by metabolic labeling.  
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Apparently, RI-ZG61 with a rapidly folding zincfinger domain was almost as efficient 
as RI-GS53, while for the folding-deficient zincfinger mutant RI-PG61 the re-
integration efficiency was decreased. The constructs RI-4xZf103/4xPf103 showed a 
similar result, however the folding-effect was not accumulative and RI-GS99 was 
clearly more efficient than RI-4xZf103. As observed for several other construct series 
RI-4xZf103/4xPf103 showed a decreased re-integration efficiency for the 19-leucine 
H-segment. Whether all four zincfingers in such closely spaced arrangement are able 
to fold is not certain.  
 
Spectrin domains are also able to rapidly fold in the ribosome exit-tunnel (Nilsson et 
al., 2017), providing a second opportunity of testing how isolated folding motifs 
influence the re-integration efficiency of the H-segment. An advantage of the spectrin 
domain is, that only one bigger domain is folding into a defined structure, thus the 
possibility that the folding of several consecutive folding domains is inefficient is 
avoided. The following spectrin sequence was cloned into RI-DP, replacing the 




The spectrin domain is shown in green, linker sequences up- and downstream of the 
spectrin domain are marked in red. The total loop length is 125 amino acids.  
As can be seen in Figure 18  the re-integration efficiency for RI-Sp125 and RI-4xZf103 
were in a similar range. However, both were less efficient than RI-GS99. We concluded 
from these experiments that the folding of the cytosolic loop affects the re-integration 
efficiency in a way that rapidly folding to a stable structure favors re-integration. In 
contrast, H-segments preceded by sequences that fail to fold into a native structure are 
less efficient in re-integration, since the folding-deficient mutants are worse in 
providing an environment suitable for efficient re-integration. The mutated zincfinger 
sequence cannot obtain its native structure, however it is unlikely that it will stay totally 
unfolded in the cytosol. Thus, it will obtain a non-native structure that we believe can 
be described as a molten globule. It remains to be shown that an H-segment after a 
folding-deficient spectrin domain is also less efficient in re-integration.  
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The comparison of the rapidly folding zincfinger and spectrin motifs, the folding-
deficient mutant and the GS repeat constructs leads to the following order, with respect 
to re-integration threshold of the H-segment: GS repeat < folded zincfinger < folded 
spectrin > folding-deficient zincfinger. This led us to the conclusion that GS repeat 
constructs and rapidly folding domains are somehow providing a similar situation, 
promoting re-integration, while folding-deficient zincfinger motifs are less favorable 
for a re-integration domain.  
 
Figure 18: Analyzing the integration behavior of a rapidly folding spectrin domain. Above: Autoradiograph of RI-
Sp125. Below: Quantification of RI-Sp125 (blue) and comparison with the other rapidly folding domain construct 
RI-4xZf103 (green), which has four zincfinger motifs in a row. The intrinsically disordered RI-GS99 (red)  and RI-
GS122 purple) are shown for comparison. All construct series integrate efficiently, with the GS repeat construct 

















Intrinsic features of the loop sequence which might affect the efficiency of re-
integration can be numerous: Folding properties and how folding of the loop affect the 
re-integration have been studied in previous chapters. Another intrinsic feature of the 
loop sequence is its ability to bind chaperones. Chaperone binding is common for most 
folding proteins in statu nascendi, To dissect how co-translational chaperone binding 
to the cytosolic loop affects the re-integration efficiency, we used sequences that are 
known for their high or low affinity to Hsp70 chaperones. Such sequences were 
identified for the ER resident Hsp70 chaperone BiP by affinity panning of libraries of 
bacteriophages (Blond-Elguindi et al., 1993). A loose consensus sequences for 
chaperone binding, which has the sequence Hy(W/X)HyXHyXHy (Hy = hydrophobic 
amino acid, W = Tryptophan, X = any amino acids), was determined. Consistent with 
the broad variety of different sequences that have to be recognized by chaperones, the 
consensus sequence shows a high redundancy. Since most cytosolic chaperones 
involved in co-translational folding are also of the Hsp70 family we assumed that the 
chaperone binding affinity to the detected sequences is similar (Clerico et al., 2015) . 




In addition to these sequences a scrambled sequence was created out of the good 
chaperone binding motif, where the overall composition of the loop remains unchanged, 
while the order of the amino acids was scrambled in a way that they do not match the 
consensus sequence. This scrambled sequence was also considered to be a low 
chaperone binding motif.  
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The cytosolic loop of RI-DP was substituted by these sequences. In each case the loop 
contained 6 good or poor chaperone binding sequences, separated by the hydrophilic 
spacer ASRSGDSA. A scheme of the loops amino acid sequences is shown in Table 2.  
 
Table 2. The loop sequences cloned into RI-DP. The good chaperone binding sequences are highlighted in blue, 
the spacers are marked in black. Bad chaperone binding sequences are shown in red and orange.  























The outcome of the experiment is shown in Figure 19. The autoradiographs and their 
quantifications confirmed our hypothesis that differences in chaperone binding affinity 
in the cytosolic loop result in clearly different re-integration efficiencies. RI-Chp109 
showed an increased efficiency, compared the non-chaperone binding constructs RI- 
nChp109. Similarly, the scrambled constructs RI-Scr109 were in a comparable 
inefficient range to RI-nChp109. This demonstrates that the re-integration efficiency of 
RI-Chp109 is caused by the high affinity to chaperones and that destruction of the 
chaperone-binding sequences by scrambling the amino acids is most likely due to poor 
chaperone binding. Furthermore, RI-Chp109 and RI-GS99 had an almost identical re-
integration threshold (3.4 leucines to 3.5 leucines), while it was significantly lower for 




Figure 19: The effect of good and bad chaperone binding sequences on the re-integration efficiency of a following 
RI-H segment. Above: Autoradiographs of the constructs RI- Chp109, RI-nChp109 and RI-Scr109 after metabolic 
labeling as described in Figure 10. Below: Quantifications of the autoradiographs for RI-Chp109 (green), RI-
nChp109 (red) and RI-Scr109 (orange). Re-integration is very efficient for RI-Chp109, while RI-nChp109 and RI-
Scr109 are less efficiently integrated. Both are in a similar range, suggesting that the effect observed is indeed due 
to chaperone binding.   
 
 
The results indicate that efficient chaperone binding to the cytosolic loop facilitates re-
integration. Cytosolic chaperones keep the nascent chain in an unfolded and folding-
competent state, thus the cytosolic loop in statu nascendi is mimicking the intrinsically 
disordered loop of the GS repeat constructs. In contrast to this, RI-nChp109 and RI-
Scr109 have a poor affinity to chaperones. However, due to the generic nature of both 
sequences they cannot fold into defined structures, leaving the formation of a molten 
globule as the most likely outcome. Formation of a molten globule decreases the re-
integration efficiency as it was already pointed out for the RI-DP constructs.  
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The findings in the previous experiments demonstrated that the efficiency of integration 
is not only dependent on the hydrophobicity of a domain alone, but is also affected by 
upstream sequence properties. However, under physiological conditions a cell needs to 
synthesize membrane proteins efficiently. Thus, cytosolic loops of natural membrane 
proteins should be evolutionary selected to fold into domains that ensure proper re-
integration of the following RI-TM domain.  
We were interested in testing cytosolic loops of natural membrane proteins, to analyze 
how they influence the integration efficiency of the following re-integration TM 
domain. To do so we chose cytosolic loops of several membrane proteins, listed in 
Table 3.  
 
Table 3: List of natural proteins chosen for the assay.  





G protein-coupled receptor GPR1 
Q12361 5 348 aa 
EPT1 
Choline/ethanolaminephosphotransferase 1 
P22140 1 109 aa 
PMA1 
Plasma membrane ATPase 1 
P05030 2 133 aa 
 
The cytosolic loops were cloned into our model protein RI-DP, using a yeast PCR 


















Figure 20: Selected natural loops were cloned into the model protein RI-DP to dissect how randomly chosen 
cytosolic loops affect the re-integration efficiency of a subsequent H-segment. A Schematic overview of the chosen 
natural proteins. TM domains are indicated in yellow. Lumenal domains are shown as a green line, cytosolic domains 
as a red line.The cytosolic loops cloned into RI-DP are marked with a red cycle B Primary sequences of the natural 
loops cloned into the model protein.. C Autoradiographs and quantifications for RI- GPR348, RI-EPT109 and RI-
PMA133. RI-GPR348 (blue) re-integrates very efficiently, compared to RI-EPT109 (green) which does not re-




Interestingly, the loops influenced the re-integration behavior of the following H-
segment very differently. While the GPR348 loop allowed for very efficient re-
integration, the PMA133 loop only produced an intermediate integration level, and 
EPT109 did not integrate even with a 19-leucine H-Segment.  
The wide range of results may appear surprising, since one might have expected that 
natural loops should be conducive top efficient re-integration. Instead, it seems that a 
re-integration-prone environment is only established by RI-GPR348.  
From the experiments in the previous parts we concluded that efficient folding of 
isolated and rapidly folding domains as well as intrinsically disordered loops facilitate 
re-integration. The efficient re-integration of RI-GPR348 suggests that the loop 
matches one of these two criteria: It is either rapidly folding into an isolated folding 
domain, or it is providing an intrinsically disordered region, which has been shown to 
facilitate efficient re-integration. We used the prediction tool IUPred2A 
(https://iupred2a.elte.hu) predict the disorder of GPR348. The prediction is shown in  
Figure 21. 
 
Figure 21: Prediction of the intrinsically disorder of RI-GPR348. The score provided for each amino acids can range 
from 0 to 1, corresponding to the likelihood of the amino acid of being part of an intrinsically disordered domain. 
 
Interestingly, the result points towards a high likelihood that the loop is intrinsically 
disordered. Especially the C-terminal part of the loop has a score of 0.8 – 1, indicating 
that this part of the sequence is most likely disordered. This explains the high re-
integration efficiency of RI-GPR348 and is in accordance with the previous results.  
The inefficiency of RI-EPT109 might be due to the fact that we have taken the cytosolic 
loop out of context into another protein sequence It might be that for efficient folding 
additional sequences in other parts of the native EPT protein are necessary and that the 
isolated EPT loop does not provide an environment which is suitable for re-integration 




3.7. Modulation of the translocon pore's hydrophobicity by 




When stop-transfer TM domains integrate into the lipid bilayer of the endoplasmic 
reticulum, the domain moves from the ribosome exit tunnel to the inside of the 
translocon, where it leaves the translocon through its lateral gate into the hydrophobic 
environment of the ER membrane. In contrast to this, the insertion mechanism for re-
integration TM domains is still elusive. Unlike stop-transfer TM domains, re-
integration TM domains need to insert together with a part of their downstream 
sequence in a hairpin-like conformation. Recently, a different model of insertion was 
proposed (Cymer et al., 2015): the hydrophobic RI domain does not enter the translocon 
pore itself, but associates directly with the surface of the ER membrane in the vicinity 
of the translocon, so that only the downstream sequence of the substrate is fully moving 
through the translocon pore (Figure 22 A).  
To contribute to this question, we modulated the hydrophobicity of the translocon pore. 
The translocon mutants Sec61-6Ala and Sec61-6Ser, which were already established in 
our lab (Junne et al., 2010), were used, where the 6 residues that constrict the translocon 
pore were substituted by 6 alanines or 6 serines. For Sec61-6Ser the pore is more 
hydrophilic, compared to wildtype, while the Sec61-6Ala mutant provides a less 
hydrated and thus more hydrophobic pore (Demirci et al., 2013). If the RI-TM domain 
indeed does not enter the pore but only associates with the ER membrane one would 
expect an increased re-integration efficiency for the hydrophilic mutant Sec61-6Ser. 
The hydrophilic downstream sequence of the substrate’s TM domain would translocate 
more easily through the translocon, enhancing the re-integration efficiency. In contrast, 
if the potential RI-TM domain inserts into the pore a hydrophilic Sec61-mutant would 
decrease the re-integration efficiency of the hydrophobic RI-TM domain. The construct 
series RI-DP124 was used to examine how an RI H-segment behaves when exposed to 




Figure 22: The interaction of the H-segment with the translocon pore  A (left)  Model for re-integration, proposed 
by (Cymer et al., 2015). The re-integration domain does not enter the pore, but places itself on the membrane instead, 
only translocating the downstream sequence. (right) The conventional model, where the RI-TM domain inserts into 
the translocon pore.  B Autoradiographs and quantifications of the RI-DP124 construct series, expressed in Sec61-
6Ala (red) or Sec61-6Ser (light green) yeast mutants, followed by metabolic labeling as in Figure 10. The 
quantifications of RI-DP124 expressed in Sec61wildtype is shown for comparison (dark green). While RI-DP124 




The autoradiographs and quantifications are shown in Figure 22 B. In general, re-
integration was found to be less efficient for the hydrophilic Sec61-6Ser mutant, 
compared to wild-type Sec61, whereas for the Sec61-6Ala mutant translocon, re-
integration efficiency was slightly increased. However, for low numbers of leucine in 
the H-segment the order of the re-integration efficiencies changed.  
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We concluded from this experiment that the hydrophobic H-segment is indeed inserting 
into the translocon pore and is not associating with the ER membrane. The results 
suggest that the hydrophobic H-Segment is repelled by the hydrophilic environment of 
the mutant Sec61-6Ser, decreasing the re-integration efficiency. This can be explained 
by the conventional model of pore-insertion of a RI-TM domain, where a potential RI-
segment wants to insert into the translocon pore but is hindered due to the hydrophilic 
environment of the Sec61-6Ser mutant pore. Accordingly, the hydrophobic mutant 
Sec61-6Ala leads to increased re-integration efficiency, since hydrophobic H-segments 






































3.8. General Discussion & Model 
 
 
We are still in the beginning of understanding how the topogenesis of multispanning 
membrane-proteins work and how the processes of translation, integration and co-
translational folding act together and influence each other. In this study we examined 
the influence of the cytosolic loop upstream of a re-integration TM domain on its 
integration behavior. Therefore, we cloned several sequences into the cytosolic loop of 
our model protein RI-DP, using intrinsically disordered loops, rapidly folding motifs, 
natural loops and loops that form a molten globule-like structure.  
We propose a re-integration mechanism that is based on the co-translational interaction 
between the potential TM domain and either the translocon or the upstream cytosolic 
loop (Figure 23)  
(1) As soon as a part of the cytosolic loop is synthesized and is experiencing the 
hydrophilic environment of the cytosol, it will not stay unfolded, but will minimize its 
free energy by collapsing to a molten globule. The process of rapidly collapsing can be 
best described as a hydrophobic collapse (see chapter 1.1). The re-integration TM 
domain can either participate in this structure of the cytosolic loop or it can insert and 
integrate into the ER membrane. In other words, the molten globule provides a 
hydrophobic environment competing with that of the translocon and the membrane for 
the TM domain. Different cytosolic loops offer more or less of this competing 
environment. Concerning our model protein, longer DPAPB fragments generally 
produce a more efficiently competing environment than shorter ones. This is in 
accordance with the finding, that truncated versions of RI-DP124 integrate more 
efficiently. However, depending on the sequence context the efficiency of molten-
globule formation can be different. This explains the reversed order of the construct 
series RI-DP124 and RI-DP95 (Figure 11). The loop of RI-DP95 forms a molten 
globule in which the H-segment can more easily participate with, compared to RI-
DP124, thus the re-integration efficiency is lower for RI-DP95. The behavior of an TM 
segment when exposed to the different environments that the loops provide is shown in 
Figure 23 B 
(2) The intrinsically disordered loops tested in this work remain unstructured and do 
not provide an alternative mildly hydrophobic phase, but thus favor insertion into the 
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ER membrane. Interestingly, differences between the molten-globule forming RI-DP 
and the intrinsically disorderd GS repeat constructs only appear for linker lengths 
longer than 50 amino acids. This might also explain why the construct from Lundin et. 
al (2008) shows a similar re-integration efficiency as RI-DP45.  
(3) Similarly, rapidly folding motifs hide their hydrophobic residues inside their folds 
and also do not interact with a potential RI-TM domain. However, mutant zincfingers 
that cannot attain the native fold are likely to collapse to a molten globule capable of 
interacting with an H-segment and therefore reducing re-integration efficiency. 
(4) Chaperone binding motifs within the cytoplasmic loop are expected to recruit 
chaperones keeping the polypeptide in an unfolded and soluble state, preventing 
collapse to a molten globule. For the scrambled version of the same sequence as well 
as for the loop composed of non-chaperone-binding motifs, the hydrophobic residues 
will again collapse and compete with membrane re-integration. 
 
Importantly, the rapidly folding of domains into isolated structures (e.g. zincfingers, 
spectrin domains), the binding of chaperones and the formation of a molten-globule are 
dynamic processes, that can influence each other. For example, the folding of the 
zincfinger domain might not be 100% efficient, resulting in a folding-deficient fraction 
of the wild-type zincfinger, that influences the re-integration behavior of the potential 
TM domain similarly to the real zincfinger mutant. A fraction of the folding-deficient 
mutant might be also bound to chaperones, preventing molten-globule formation. On 
the other hand, chaperone-binding sequences might not bind chaperones 100% 
efficient, resulting in the partial collapse of the sequence into a molten-globule. We 
tried to examine these processes as isolated as possible. However, one has to be careful 
when evaluating the integration efficiency of totally different molten-globule forming 
sequences, since each sequence has its own intrinsic capacity to collapse into a molten-
globule. The inversed integration efficiencies of the constructs RI-DP124 and RI-DP95 
demonstrate this problem. The natural cytosolic loops we tested are another example. 
Only the construct RI-GPR348 has a high re-integration efficiency, which is due to the 
intrinsically disordered state of a major part of the sequence. The other sequences are 
taken out of their natural context, thus it remains elusive whether they can fold into 
their native structure in the context of our model protein. Maybe additional parts of the 
up- and downstream sequences are required for efficient folding and without those they 
collapse into a molten-globule.  
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Figure 23: Model for re-integration. When the RI TM domain emerges from the ribosome exit tunnel it can either 
engage with the translocon, which leads to integration (right arrow) or it can participate in the formation of a molten 
globule. When a sequence collapses into a molten globule, the H-segment can participate in this formation, reducing 
re-integration efficiency (1). For intrinsically disordered regions, isolated folding motifs and chaperone binding 
sequences such an interaction is not possible or strongly reduced (2-4). Since no molten globule is formed the H-




In some cases we observed a decreasing re-integration efficiency for H-segments with 
19 leucines. In the beginning, this was surprising for us and we still do not have a 
solution to this problem. Our hypothesis is that the strong hydrophobicity of the 19 
leucines H-Segment favors molten-globule participation since pore insertion is less 
favorable. For re-integration the H-segment has to enter the pore in a hairpin-like 
structure together with the hydrophilic downstream sequence. The formation of this 
hairpin might be energetically disfavored for very hydrophobic H-segment. It seems 
that for constructs with intrinsically disordered loops the reduction does not occur (RI-
GPR348 and RI-Nup109). This might be due to the fact that for intrinsically disordered 
loops no molten-globule is formed, thus the only possibility for the H-segment to reduce 
its free energy is to insert into the ER membrane.  
 
How does the cycloheximide experiment fit into this model? CHX slows down the 
translation rate, but the folding processes are of course not directly affected by CHX. 
We think that there is an indirect influence: the possibility for the H-segment to 
participate in the molten-globule formation is reduced. To effectively participate in a 
molten-globule the sequence downstream of the H-segment is required to have a certain 
length, to allow the H-segment to diffuse away from the ribosomal exit tunnel into the 
cytosol. A short downstream sequence can be seen to act as a `leash` that is tethered to 
the ribosomal active site, preventing the H-segment to diffuse away by holding it back 
in close vicinity to the translocon. Since CHX slows down the translation process the 
C-terminal `leash´ grows longer more slowly. Thus, the H-segment spends more time 
in the intermediate area between the ribosome exit tunnel and the translocon pore, 
resulting in an increased likelihood that it inserts into the pore.  
 
Taken together, we suggest a model in which the process of re-integration is not only 
dependent on the hydrophobicity of the potential TM domain, but is also strongly 
influenced by the characteristics of the preceding cytosolic loop. Integration (into the 
ER membrane) or participation (with a molten-globule) is dependent on an interplay 
between the hydrophobicity of a potential TM segment and the capacity of the cytosolic 
loop to collapse into a molten-globule. Preventing of the hydrophobic collapse into a 
molten-globule – either by chaperone-binding or isolated folding - increases the re-
integration efficiency, since participation of the potential TM domain with the molten-




The model we propose needs further validation. To do so, we plan to test more 
intrinsically disordered domains. Independent of the sequence context intrinsically 
disordered domains should always provide an environment that favors integration. In 
addition to that, we plan to destroy the rapidly folding spectrin domain in construct RI-
Sp125. Upon destruction of the folding motif, a molten globule should be formed, thus 
re-integration efficiency should be lower. For the chaperone binding constructs we plan 
to quantify the amount of chaperones bound to the cytosolic loops. The most likely 
interactors are the cytosolic chaperones Ssa and Ssb. Unfortunately, co-



















PART II: THE NATURAL 
PRODUCT CAVINAFUNGIN SELECTIVELY INTERFERES 
WITH ZIKA AND DENGUE VIRUS REPLICATION BY 






The proper translocation and processing of polypeptides through membranes is a crucial 
step in the secretory pathway of pro- and eukaryotes. In principle, this makes the 
translocon a potential target for antibiotic interference, since selective inhibition of this 
step in prokaryotes would provide a useful tool to fight bacterial infections .  
However, the machinery that translocates polypeptides through the plasmamembrane 
of bacteria (SecYEG) is well conserved and shows homology to the eukaryotic 
counterpart (Sec61abg), which is required for the translocation of polypeptides into the 
endoplasmic reticulum (Park and Rapoport, 2012). This makes it unlikely that a 
compound selectively blocks the prokaryotic translocon. However, other proteins that 
participate in the translocation process are less conserved. While the signal peptidase is 
functionally conserved, it is sufficiently different in structure to be a potential target for 
antibiotic interference (Auclair et al., 2012).  
Signal peptidases (SPase) cleave the signal sequence of a variety of polypeptides during 
translocation, a crucial step in polypeptide processing. The E.coli signal peptidase 
(Leader peptidase ) is among the most studied and best characterized peptidases 
(Dalbey, 2013). It was found to be a monomeric membrane protein, cleaving the signal 
sequence via a catalytic dyad, involving the amino acids serine and lysine and is as such 
classified as a serine-protease (Dalbey, 2013). In contrast, eukaryotic signal peptidases 
are multi-subunit complexes. The exact stoichiometry still remains elusive. The yeast 
signal peptidase involves at least four subunits (Sec11p, Spc1p, Spc2p, Spc3p), with 
Sec11p as the catalytic subunit. The mammalian counterpart is composed of five 
subunits (SPC25, SPC22/23, SPC21, SPC18 and SPC12). SPC12 and SPC18 are 
isoforms and homologous to the yeast Sec11p, thus also contain the active site, which 
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was identified to be a serine-protease, acting over a Serine-Histidine-Aspartate tryad 
(Walker and Lively, 2013). In mammals, impaired cleavage of hormones has been 
shown to lead to diseases, like diabetes insipidus (Ito et al., 1993). While most protease 
inhibitors lack the ability to block signal peptidase activity, the bacterial signal 
peptidase was found to be inhibited by b-lactam derivatives (Therien et al., 2012). 
Interestingly, signal peptides itself have been found to be competitive inhibitors of the 
signal peptidase, like the signal sequences of mutant forms of the hormones 
preproinsulin and preproparathyroid. In addition to that, it was found a mutant of the 
maltose-binding protein, where the cleavage site at position +1 is mutated to a proline 
can also inhibit the prokaryotic signal peptidase (Barkocy-Gallagher and Bassford, 
1992). For the mammalian signal peptidase no chemical inhibitors had been identified 
prior to this study (Dalbey, 2013; Walker and Lively, 2013).Not only compounds 
against bacterial targets are of great interest, but also compounds against viral 
infections. Viruses hijack cells and exploit the cellular machinery for replication. One 
of the most dangerous viral infections is caused by the mosquito-borne dengue virus, 
which is a flavivirus, like the zika virus. The dengue virus is responsible for more than 
20 000 deaths per year (Bhatt et al., 2013). Until now, neither vaccines nor antiviral 
compounds are available.  
The 11kb viral mRNA of the dengue virus is translated into a single polyprotein by the 
cellular ribosome in the cytosol. To mature, an interplay between viral and host 
proteases cleave the polyprotein at several internal cleavage sites into the final proteins 
(Figure 24) (Perera and Kuhn, 2008). While the structural proteins C, prM and E form 
the virion, the other 7 proteins (NS1, NS2A/B, NS3, NS4A/B, NS5) fulfill different 
cellular functions in hijacking the cell and are in total responsible for the cellular 
replication of the viral RNA (Norazharuddin and Lai, 2018).  This demonstrates, that a 
functional signal peptidase is crucial for the correct processing of the viral polyprotein 
and that a compound that inhibits processing or leads to apoptosis of infected cells is of 






Figure 24: Topology and processing of the dengue virus-polyprotein. The polyprotein is processed by viral and cellular signal 
peptidases. The 4 cleavage sites for the ER signal peptidase are denoted by a blue arrow. The viral protease NS2B-NS3 cleaves at 






















5. Aim  
 
 
To find new therapeutic leads Dominic Höpfner and colleagues (Novartis) screened 
several compounds for their inhibitory activity against dengue- and zika-virus infected 
cell lines. The lipopeptide cavinafungin showed an up to 100-fold stronger activity in 
infected cell lines compared to uninfected cells. To identify the target of cavinafungin, 
chemogenomic assays in mammalian cells and yeast were performed. In both cases the 
host’s signal peptidase was identified as a possible target.  
 
The aim of this part was to verify whether cavinafungin indeed targets the signal 
peptidase. To do so, we used a metabolic radiolabeling approach in mammalian cell 
lines, testing the ability of the signal peptidase to cleave the signal sequences of pre-
proinsulin and pre-provasopressin as well as some precursors of the dengue virus-
polyprotein when exposed to cavinafungin in a dose-dependent manner. 
We could verify the inhibition of the signal cleavage upon treatment with cavinafungin 
for host and viral proteins, demonstrating that the target of cavinafungin indeed is the 
signal peptidase. Whether cavinafungin also inhibits the signal peptidase of bacteria 
still has to be elucidated.  
 
The results were published 2017 in Cell reports. The following chapter contains the 
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SUMMARY
Flavivirus infections byZika anddengue virus impose
a significant global healthcare threatwith noUSFood
andDrugAdministration (FDA)-approvedvaccination
or specific antiviral treatment available. Here, we pre-
sent the discovery of an anti-flaviviral natural product
named cavinafungin. Cavinafungin is a potent and
selectively active compound against Zika and all
four dengue virus serotypes. Unbiased, genome-
wide genomic profiling in human cells using a novel
CRISPR/Cas9 protocol identified the endoplasmic-
reticulum-localized signal peptidase as the efficacy
target of cavinafungin. Orthogonal profiling in
S. cerevisiae followed by the selection of resistant
mutants pinpointed the catalytic subunit of the signal
peptidase SEC11 as the evolutionary conserved
target. Biochemical analysis confirmed a rapid block
of signal sequence cleavage of both host and viral
proteins by cavinafungin. This study provides an
effective compound against the eukaryotic signal
peptidase and independent confirmation of the
recently identified critical role of the signal peptidase
in the replicative cycle of flaviviruses.
INTRODUCTION
Flavivirus infections, including Zika and dengue virus infections,
are mosquito-borne viral diseases with more than 100 million
infections per year. Geographic distribution of infections is
focused in the tropics and subtropics, a region covering 128
countries and inhabited by more than 3.9 billion people (Bhatt
et al., 2013; Brady et al., 2012). The recent reports of Zika virus
outbreaks and suspicion of detrimental effects on embryonic
development, in particular cerebral development (Cugola et al.,
2016), raise awareness of the fact that to date, there is no US
Food and Drug Administration (FDA)-approved vaccination or
specific treatment available.
In the search for novel antiviral intervention points, there have
been three recent independent reports where genome-wide ge-
netic screens investigated host factors that are required for effi-
cient replication of the dengue virus (Ma et al., 2015; Marceau
et al., 2016; Savidis et al., 2016; Zhang et al., 2016). They all iden-
tified endoplasmic reticulum (ER)-associated functions, including
protein processing,maturation, andmodification asessential host
factors for the viral life cycle. In particular, the study by Zhang and
colleagues outlined the importance of the host ER-associated
signalpeptidase (SPase) for processingof theprMandEstructural
proteins common to all flaviviruses (Zhang et al., 2016). However,
whereas the signal peptidase is an established target for antibac-
terials with several reported inhibitor classes, to the best of our
knowledge, no cellular active and selective eukaryotic signal
peptidase has been reported to date.
Here, we report that a recently identified alaninal-containing
lipopeptide of fungal origin, cavinafungin (Ortı́z-López et al.,
2015), potently inhibits growth of dengue- and Zika-virus-in-
fected cells with significant selectivity over non-infected cells.
We established an unbiased genome-wide CRISPR/Cas9 che-
mogenomic profiling approach and identified the ER-associated
SPase as the likely efficacy target of cavinafungin. This was veri-
fied by haploinsufficiency profiling in yeast, raising of resistant
mutants, biochemical testing, and direct analysis of signal
sequence processing in mammalian cells. This study provides
the first compound against the eukaryotic signal peptidase and
pharmacological confirmation of the critical role of the SPase
in the replicative cycle of flaviviruses.
RESULTS
Cavinafungin Inhibits Zika- and Dengue-Virus-Infected
Cells
To identify novel therapeutic leads, we tested compounds of
various origins in a dose-response fashion for inhibitory activity
against dengue- and Zika-virus-infected cells. The recently
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identified linear lipopeptide cavinafungin isolated from the fungus
Colispora cavincola (Ortı́z-López et al., 2015) (Figure 1A) displayed
potent cellular activity against all four dengue serotypeswithmore
than 100-fold selectivity over uninfected cells (Figure 1B). This
activity was consistent across multiple cell types, in particular in
human peripheral blood mononuclear cells (hPBMCs), which
contain monocytes, thought to be one of the clinically relevant
cells for dengue (Jessie et al., 2004). Expanding to other flavivi-
ruses also revealed potent activity against Zika virus, with
!30-fold selectivity compared to the cytotoxic effect of the com-
pound (Figure 1B). Cavinafungin was however inactive against
other types of viruses, like chikungunya virus (Figure 1B), cyto-
megalovirus, and herpes simplex virus (data not shown). Cavina-
fungol, the reduced alcohol derivative of the cavinafungin alde-
hyde, revealed significantly reduced activity and a collapse of
the therapeutic index, indicating that the aldehyde moiety was
important for antiviral activity (Figures 1C and 1D).
Chemogenomic Profiling Using CRISPR/Cas9 Identifies
Subunits of the Signal Peptidase
Inhibition of viral components or host cell processes can account
for the observed antiviral activity. To identify a possible host
target, we profiled cavinafungin in a genome-wide compound/
CRISPR experiment (Figures 2A and 2B). We hypothesized
thatmutations in the target and pathway directly affected by cav-
inafungin would result in selective hypersensitivity and fitness
defects upon exposure to sublethal doses of cavinafungin as
recently shown for an inhibitor of NAMPT (Estoppey et al.,
2017). Plotting the redundant siRNA activity (RSA) p value
(a gene-level measure for conserved depletion of its respective
guides) against Q1 (a gene-level effect size corresponding to
the RSA p value) (König et al., 2007) identified only few genes
that separated from the pool (Figure 2C). These hits were
conserved across both experiments as visible when plotting













































































































































































Figure 1. Cavinafungin Is a Potent and Selective Inhibitor of Cells Infected by Dengue Virus
(A) Chemical structure of cavinafungin and its inactive alcohol derivative.
(B) Inhibition and cytotoxicity concentrations of cavinafungin and cavinafungol on different dengue virus serotypes (DV), Zika virus (ZV), and chikungunya virus
(CHIKV) in different cell lines. Note that chikungunya is not a flavivirus family member, and cavinafungin did not score significant antiviral activity against this virus.
(C) Inhibition and cytotoxicity concentrations of cavinafungol on different dengue virus serotypes in different cell lines. For those values with a CV indicated, at
least two independent biological replicates were measured.
(D) Selectivity index as calculated by the log2 ratio of antiviral activity over cytotoxicity.
IC, inhibitory concentration; CC, cytotoxicity concentration; CV, coefficient of variation; n.d., not determined.
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Figure 2. Genome-wide CRISPR/Cas9 Profiling of Cavinafungin in HCT116 Cells Identifies Two Subunits of Signal Peptidase
(A) Schematic representation of the experimental setup.
(B) Potency determination of cavinafungin against HCT116 cells by dose-response testing using two biological replicates.
(C) Profiles of genome-wide CRISPR/Cas9 profiling experiment of cavinafungin at IC10 and IC30 concentrations, respectively. Graphs show relative abundance of
gRNAs against DMSO control, averaged to gene-level resolution as calculated by logP RSA (a gene-level measure for conserved depletion of its respective
(legend continued on next page)
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identified CFLAR, a regulator of apoptosis, and ABCC1, encod-
ing an ABC transporter involved in pleiotropic drug resistance
(Hipfner et al., 1999), which are likely to affect cavinafungin ef-
fects indirectly, and SLC33A1, which is annotated as a probable
acetyl-coenzyme A (acetyl-CoA) transporter. Noticeably, three
additional hits act in a pathway recently reported to be required
for efficient viral replication (Zhang et al., 2016): HSP13A, an
HSP70 family chaperone involved in folding of secretory proteins
(Yang et al., 2015), and SEC11A and SPCS3, encoding essential
functions for the catalytic activity of the ER-associated SPase
complex (Böhni et al., 1988; Fang et al., 1997; Shelness et al.,
1993). The SPase complex also contains two additional regula-
tory subunits, SPCS1 and SPCS2, and a presumed paralog of
SEC11A, SEC11C (Mullins et al., 1996). Guide RNAs (gRNAs)
for these subunits did not separate from the pool, but analyzing
the results of each of the five individual gRNAs showed dose-
dependent cavinafungin effects on all five gRNAs (Figure 2E),
suggesting at least some moderate effect. Previous expression
analysis in HCT116 cells revealed significantly higher expression
of SEC11A than of the presumed paralog SEC11C, thus likely ac-
counting for the predominant dependency on SEC11A (Junne
et al., 2015). Testing the best-scoring gRNAs individually in
cavinafungin dose-response experiments supported significant
hypersensitivity of cells edited for SEC11A, SPCS3, and to a
lesser extent SPCS2 but no significant effects on the other
SPase subunits (Figure 2F).
Chemogenomic Profiling in Budding Yeast Supports
SPase as Cavinafungin Site of Action
Since the SPase complex is highly conserved in eukaryotic cells
and cavinafungin was reported to also have antifungal activity
(Ortı́z-López et al., 2015) (Dataset S1), we decided to intersect
the mammalian data with another unbiased, genome-wide
approach: haplosinsufficiency profiling (HIP) and homozygous
profiling (HOP) in fungal S. cerevisiae cells (Giaever et al.,
1999; Hoon et al., 2008; Lee et al., 2014). HIP identifies proteins
and/or pathways directly affected by the compound, whereas
HOP can reveal synthetic lethal effects and delineate compen-
sating factors and/or pathways. The results are visualized by
plotting the relative growth reduction of individual HIP/HOP
strains by the compound (sensitivity) versus a measure of signif-
icance (Z score) (Hoepfner et al., 2014). We tested cavinafungin
at 30% inhibition concentration (IC30) in two independent exper-
iments (Figures 3A, 3B, S1A, and S1B). Interestingly, cavina-
fungin scored IC50 values in a range between 0.5 and 3.5 mM
(Figures 3D and S1C), similar to the ranges observed for
mammalian cells (Figures 1B and 2B). In both unbiased,
genome-wide HIP experiments, strains carrying deletions in
SEC11 and SPC2 encoding for the catalytic and a regulatory
SPase subunit scored as the top hits. Additional gene hits
included SPC3, another SPase subunit essential for catalytic ac-
tivity, SEC21, encoding a component of the coat protein com-
plex I (COPI) coat required for trafficking from ER to Golgi (Gay-
nor and Emr, 1997), and ERD2, coding for the His-Asp-Glu-Leu
c-terminal tetrapeptdide motif (HDEL) receptor mediating reten-
tion/retrieval of ER proteins (Gaynor and Emr, 1997; Semenza
et al., 1990). HOP profiling identified the nonessential SPC2
SPase subunit gene as well as HAC1 and IRE1, which are
involved in the ER stress response, and SIL1, which is associ-
ated with an ER Hsp70 chaperone, and all are involved in ER
quality control (Figure 3B). All hits were validated in single-strain
dose-response experiments (Figure S1C). Hypersensitivity of the
SPC2 knockout (KO) strain in the HOP experiment ruled out this
component as the primary pharmacological target of cavinafun-
gin, pin-pointing the catalytic SPase subunit Sec11 as the likely
candidate. Conserved action against the fungal and mammalian
catalytic SPase subunit was assessed by replacing the Saccha-
romyces cerevisiae (S.c). SEC11 gene with the mammalian
SEC11A cDNA. The resulting yeast strain was viable, demon-
strating functional complementation of the human SEC11A pro-
tein, and!10-foldmore susceptible to cavinafungin, with an IC50
almost identical to that measured in mammalian cells (Fig-
ure S2A). Cavinafungol did not exert any growth inhibitory effect
against both strains up to the highest tested dose (Figure S2B).
Mutations in the Catalytic SPase Subunit Cause
Cavinafungin Resistance
To corroborate the SPase target hypothesis, we deployed a
focused mutagenesis approach. The cDNAs for S.c. SEC11,
SPC1, SPC2, and SPC3 were amplified by error-prone PCR,
cloned into low-copy-number plasmids under the control of the
endogenous promoter and terminator elements, and transformed
into yeast cells heterozygous for the corresponding gene (Huang
et al., 2013). 107 plasmid-harboring cells per gene were plated
onto growth-inhibitory concentrations of cavinafungin. No resis-
tant colonies could be isolated from the SPC1, SPC2, and SPC3
plates. In contrast, 28coloniesconferring resistance to highdoses
of cavinafungin were isolated from the SEC11 plates, and nine
distinctmutations inSEC11were identified (Figure3C). Tovalidate
genotype-phenotype linkage, these mutations were introduced
into wild-type cells and subjected to dose-response testing. All
mutations resulted in notable resistance up to the highest dose
tested (100 mM), but to different degrees (Figure 3D). Resistance
to cavinafungin was dominant over the wild-type copy of SEC11
still present in the cells. The majority of mutations (seven out of
nine) localized to or near a triple valine motif in the peptidase
domain around position 38–40, one to a triple valinemotif at posi-
tion 71, and one further downstream in the peptidase domain. To
investigate if these sites outline a distinct structuralmotif, we used
the published crystal structure of S. pyogenes SPase, the closest
guides) and Q1 (a gene-level effect size corresponding to the RSA p value) (König et al., 2007). Signal peptidase subunits are labeled by the colors refer-
enced in (F).
(D) Alignment of the logP values of both experiments illustrate reproducibility and robustness.
(E) Log2-fold changes of individual gRNAs of selected hits from the two genome-wide profiling experiments.
(F) Single gRNA validation of SPase subunits. The best-scoring gRNA for each gene identified in the genome-wide experiment was individually tested. Curves
were fitted on data from three biological replicates. The number of asterisks indicates the number of SDs separating the curve from that of the non-coding gRNA
experiment. A gRNA against the SPase unrelated ER protein PIGA was used as a second control.
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Figure 3. Chemogenomic Profiling of Cavinafungin in S. cerevisiae Supports the Catalytic SPase Subunit Sec11 as a Primary Target
(A) Alignment of two independent cavinafungin haploinsufficiency profiling (HIP) experiments. Three out of four components of the SPase complex (SEC11, SPC2,
and SPC3) and key components in the secretory pathway (SEC21 and ERD2) reproducibly scored as hits.
(B) Alignment of two independent homozygous profiling (HOP) experiments reproducibly identified the ER stress response components HAC1/IRE1/SIL1 to be
synthetic lethal with cavinafungin action, supporting disruption of proteostasis at the level of the ER. Deletions in essential genes are labeled by gray boxes and
deletions in nonessential genes by black dots. The dotted line to HAC1 represents the YFL032W deletion strain, an open reading frame not yet identified to
encode a protein but overlapping the HAC1 gene.
(legend continued on next page)
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yeast and mammalian SPase homolog for which a structure was
available (Young et al., 2014). Mapping the yeast mutations into
the 4N31 crystal structure of the related SPase of S. pyogenes
(Young et al., 2014) outlined the signal-peptide-binding cleft adja-
cent to the protease active site (Figures 3E and 3F; Dataset S1).
We hypothesized that the identified mutations interfere with cavi-
nafungin binding into the peptide-binding cleft.
Cavinafungin Shows Differential Inhibition in SPase KO
Cells
To verify that Cavinagfungin was exerting its efficacy on dengue
through the inhibition of the host SPase, we evaluated whether
the compound anti-dengue activity was affected by editing of
SPase components via CRISPR/Cas9. We evaluated the IC50
of Cavinagfungin in cells upon transient editing of SEC11A,
SPCS1, and SPCS3 using up to three different gRNAs for each
gene. NITD008, a nucleoside shown to directly inhibit the
RNA-dependent RNA polymerase activity of dengue virus and
thus a mechanism independent of SPase, was used as control
(Yin et al., 2009).
Cells where SPase components were edited showed a
consistent >10-fold decrease of cavinafungin in vitro efficacy
compared to untreated wild-type control (Figure 3G).
Conversely, the efficacy of the nucleoside NITD008 remained
unaffected (<2-fold) in cells treated with the same gRNAs
(Figure 3G). This lack of effect from a genetic KO of the various
components of SPase on the efficacy of NITD008 is expected
considering that the compound inhibits the viral polymerase
directly. Together, the loss of efficacy measured by an increase
in the IC50 fold change was significantly different (p < 0.0001) for
cavinafungin compared with NITD008 in cells where SEC11A,
SPCS1, or SPCS3 was targeted by CRISPR/Cas9.
Cavinafungin Inhibits Viral Polyprotein Processing and
Signal Peptide Cleavage of Host Proteins
The dengue virus encodes a single polyprotein that has to be
processed co- and post-translationally by viral and host prote-
ases to yield three structural proteins (Figure 4A) (Lindenbach
et al., 2007). Four cleavages (prM, E, NS1, and NS4B) are per-
formed by host SPase. Thus, SEC11A inhibition could very well
explain the observed antiviral activity of cavinafungin and is
supported by recent genetic experiments (Zhang et al., 2016).
In order to study the effect of cavinafungin on SPase cleavage
of the viral precursor protein, we transfected cells with con-
structs C14-prM-E and 2K-NS4B-V5 (Figure 4A). Western blot
analysis revealed that 1 mM cavinafungin strongly reduced the
levels of (C14-)prM and E proteins released from the C14-prM-E
construct and enhanced the level of the full-size precursor
(C14-)prM-E (FL; recognized on western blots only by the anti-E
antibody) (Figure 4B, left), indicating inhibition of SPase cleavage
at site 2. No effect was detected with 1 mM cavinafungol. Inhibi-
tion by cavinafungin was dose dependent, with a weightedmean
IC50 of 0.73 ± 0.08 mM (Figure 4B, right; Table S1). Similarly, upon
expression of 2K-NS4B-V5, the presence of 1 mM cavinafungin,
but not cavinafungol, induced the vast majority of products to
shift to a higher molecular weight corresponding to the
uncleaved 2K-NS4B-V5 (Figure 4C, left). Accumulation of the
uncleaved protein was dose dependent, with a weighted
IC50 mean of !0.08 ± 0.01 mM (Figure 4C, right; Table S1).
We also analyzed inhibition of SPase cleavage by metabolic
labeling to detect the immediate translation products rather
than steady-state levels. Available antibodies allowed us to
immunoprecipitate and distinguish the precursor (C14-)prM-E
(FL) and the products of cleavage at site 2 alone, C14-prM, or
at both sites 1 and 2, prM (Figure 4D). As summarized in Table
S1, cavinafungin added during the labeling period inhibited
cleavage, with a weighted IC50 mean of 0.49 ± 0.11 mM at site
1 and 0.17 ± 0.01 mM at site 2. Expression of 2K-NS4B-V5 (Fig-
ure 4E) revealed a considerable amount of uncleaved product,
even in the absence of inhibitor, most likely the result of
inefficient ER targeting of the viral protein fragment and not
detectable in the western blot because of rapid degradation.
Cavinafungin inhibited cleavage at site 4, with an IC50 of
1.8 ± 0.01 mM. Taken together, the viral SPase cleavage sites
were inhibited with similar efficiencies by cavinafungin, with a
weighted IC50 mean of 0.87 ± 0.01 mM.
SPase inhibition is expected to also compromise processing
of host proteins. We assessed cleavage of two host secretory
proteins at increasing cavinafungin concentrations, pre-prova-
sopressin and pre-proinsulin, both of which are known to pro-
duce a detectable shift in electrophoretic mobility when the
signal peptide is retained (Beuret et al., 1999; Cui et al., 2015).
Transfected HeLa cells producing pre-provasopressin and
INS-1E insulinoma cells endogenously expressing pre-proinsulin
were metabolically labeled, immunoprecipitated, and analyzed
by SDS-gel electrophoresis and autoradiography (Figures 4F
and 4G). Cavinafungin caused accumulation of the larger,
uncleaved protein forms, with an IC50 of !0.91 ± 0.15 mM for
pre-provasopressin and 3.29 ± 0.3 mM for pre-proinsulin. As
summarized in Table S1, cavinafungin inhibits cleavage at the
viral and host cleavage sites at similar concentrations and close
to the IC50 values measured for growth and cytotoxicity of
different cell lines (Figure 1B). The alcohol form of cavinafungin,
in contrast, only produced minimal signal cleavage inhibition at
much higher concentrations, in agreement with the observed
minimal inhibition of cell growth (Figure 1C). These experiments
(C) Induced mutagenesis followed by selection on growth-inhibitory concentrations of cavinafungin identified mutations in the peptidase domain of the SEC11
gene that confer resistance. Position, amino acid changes, and frequencies are indicated.
(D) Validation of resistance by cloning of the identified mutations into fresh wild-type strains and measuring dose-response curves of three technical replicates.
(E) Structure 4N31 of S. pyogenes SipA, the closest yeast/human SPase homolog with a solved crystal structure. The proposed active site is labeled by blue
asterisks.
(F) The homologous residues identified to give cavinafungin resistance are labeled in black, and the catalytic dyad residues of the protease are depicted in blue.
The first letter depicts the Streptococcus pyogenes (S.p.). SipA residue and the second the corresponding S.c. Sec11p residue. The dotted box delimits the area
enlarged in (E).
(G) Effect of knocking out components of the SPase complex on the in vitro efficacy of cavinafungin or on the RNA-dependent polymerase inhibitor NITD008. The
different shapes represent different gRNAs used per gene. ***p < 0.0001 using a two-way multiple comparisons ANOVA with Sidak corrections.
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provide biochemical evidence for inhibition of the SPase activity
by cavinafungin as predicted by the chemogenomic profiling
experiments.
DISCUSSION
In phenotypic screens against Zika and dengue virus, we have
discovered the recently identified natural methylproline-contain-
ing lipopeptide compound cavinafungin (Ortı́z-López et al., 2015)
to be a selective antiviral agent. Using a suite of genetic and
finally proteomic and biochemical assays, we have identified
cavinafungin to be a selective, cellular active inhibitor of the
ER SPase. Although there are a variety of compounds in the
literature that are reported to target the bacterial enzyme
(Craney and Romesberg, 2015), to the best of our knowledge,
this is the first identification of a selective eukaryotic SPase
inhibitor.
SPase is an essential, membrane-bound serine protease com-
plex involved in cleavage of the signal peptides of newly synthe-
sized secretory and membrane proteins at the ER. SEC11A and
SPCS3 are necessary for the cleavage activity (Fang et al., 1997;
Meyer and Hartmann, 1997), but only SEC11A so far was
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Figure 4. Biochemical Confirmation of Signal Peptide Cleavage Inhibition by Cavinafungin of Viral and Human Substrates
(A) Schematic representation of the dengue polyprotein and of constructs used to investigate inhibition of processing by cavinafungin (Cav) and cavinafungol
(Cav-OH). SPase cleavage sites are indicated by black triangles and numbered.
(B andC) Effect of Cav andCav-OH onHEK293T cells transfected with C14-prM-E (B) or 2K-NS4B-V5 (C) as identified bywestern blot. The blots represent one out
of two to four independent experiments. 17- to 19-kDa bands are indicated as various forms of prM, and E and uncleaved prM-E (FL) are detected as 50- and
70-kDa bands, respectively. GAPDH was probed as control.
(D and E) Effect of Cav on cells transfected with C14-prM-E (D) or 2K-NS4B-V5 (E) as determined by labeling experiments.
(F and G) Effect of Cav and Cav-OH on human pre-provasopressin (F) and INS-1E insulinoma cells endogenously expressing pre-proinsulin (G) as determined by
labeling experiments.
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identified to contain a signal-sequence-binding domain and
classic serine protease dyad motif (Fang et al., 1997). To date,
no crystal structure of any eukaryotic SPase subunit is available
that would allow for predictive cavinafungin in silico docking ap-
proaches. However, it is plausible that membrane anchoring of
cavinafungin via its lipophilic tail orients the oligopeptide moiety
to be recognized as a signal peptide in the SEC11A peptide-
binding cleft and engaging the catalytic serine of the protease
by the reactive aldehyde via a nucleophilic attack. This results
in formation of a covalent hemiacetal intermediate, the classic
serine protease inhibitionmechanism (as reviewed byHedstrom,
2002). This hypothesis is supported by several lines of experi-
mental evidence presented in this report: (1) the aldehyde group
of cavinafungin is critical for activity (Ortı́z-López et al., 2015), (2)
the signal-peptide-binding subunit SEC11A was the only one for
which resistance conferring mutations could be isolated, (3) the
identified resistance-conferring residues outline the signal pep-
tide binding cleft, and (4) cavinafungin has a peptidic moiety
that fulfills the "1 and "3 rules (Ala and Val) of a signal peptide
(von Heijne, 1990)
In addition to reporting the first mammalian SPase inhibitor,
we also demonstrate that cleavage by SPase is critical for flavi-
virus polyprotein processing. In particular, we provide support
that the inhibition of dengue by cavinafungin is directly mediated
via inhibition of the SPase by showing that the compound loses
in vitro efficacy in cells where the SPase complex is genetically
targeted by CRISPR/Cas9. We also we provide experimental
support that the 2K domain upstream of NS4B and the C14
domain upstream of the prM protein, two transmembrane do-
mains, are cavinafungin sensitive and thus likely processed
with involvement of the SPase, as previously suggested (Linden-
bach et al., 2007).
The prM-E junction shows the highest degree of inhibition by
cavinafungin, with an IC50 of 0.19 ± 0.01 mM, compared to the
inhibition of pre-proinsulin or the cytotoxicity measured of
!1.34 ± 0.18 mM, which corresponds to a selectivity of
!7-fold. The effect of prM-E would therefore not explain on its
own the selectivity observed. We attribute the hypersensitivity
of infected cells to the fact that virus production and virion as-
sembly require four SPase cleavages (host proteins only one
site), that partially cleaved fragments are unstable, as observed
for unprocessed C14-prM-E (Figure 4B), and that non-stoichio-
metric amounts of viral proteins might exert a dominant-nega-
tive effect on viral replication and assembly; for example, prM
acts as a folding chaperone for E (Roby et al., 2015). Folding
stress is likely potentiated by the sheer load of virus production,
far exceeding the normal volume of endogenous secretory load
in uninfected cells.
Based on the tight homology of the sequences acrossmultiple
viruses in this family (Figure S3), the activity of cavinafungin is
likely to impact other members of the flavivirus family. The
sequence alignment shows that these regions are highly
conserved (Figure S3), particularly the small, uncharged residues
required at "1 and "3 sites and the upstream hydrophobic
stretch that are predictors for SPase cleavage (von Heijne,
1990). This notion is indeed supported by our data showing
that Zika virus replication is also inhibited by cavinafungin, thus
matching previously reported effects on both dengue and Zika
virus replication when SPase was compromised by genetic
means (Zhang et al., 2016).
Our study demonstrates the power of unbiased, genome-wide
CRISPR/Cas9 compound profiling in mammalian cells for identi-
fying the mechanism of action of compounds. In particular, the
intersection with chemogenomic profiling data from yeast and
genetic follow up experiments in this organism allowed conclu-
sive target identification of the first cellular active, selective,
eukaryotic SPase inhibitor. This chemical biology dataset cor-
roborates recent genetic findings that highlight the host SPase
complex as an Achilles heel of flaviviruses (Zhang et al., 2016)
and provides a research compound for further dissection of
the viral life cycle, in particular to gain a better understanding
of polyprotein processing. Finally, the observed differential anti-
viral activity raises the hope that this node can be therapeutically
exploited for urgently needed, novel antiviral therapies.
EXPERIMENTAL PROCEDURES
Compound Isolation and Handling
Cavinafungin was isolated from cultures of an unclassified fungal strain and
purified according to a previously described method (Ortı́z-López et al.,
2015). Compound structure was confirmed by high-resolution mass spec-
troscopy and nuclear magnetic resonance (NMR). Sample purity was found
to be >90% according to high-performance liquid chromatography (HPLC)
analysis. The compound was stored as powder at 4#C until use and dissolved
in 100% DMSO to a stock concentration of 10 mM. Solutions were kept at
4#C for up to 6 months.
High-Content Imaging Cell-Based Flavivirus Immunodetection
Assay
In brief, 7 3 103 A549 cells per well in a 384-well plate were infected at MOIs
of 0.5, 0.3, 2, and 1 DENV-1(MY97-10245), DENV-2(MY97-10340), DENV-
3(MY05-34640), and DENV-4(MY01-22713), respectively, in the presence of
3-fold 10-point serial dilutions of the compound. 8 3 103 HUH7 cells per well
in a 384-well plate were infected at an MOI of 2 for DENV-2 (My97-10340) in
the presence of 3-fold, 10-point serial dilutions of compounds. At 48 hr postin-
fection (p.i.), the infected wells were washed, fixed, and labeled with Dylight-
488-conjugated 4G2 Antibody (Genescript). Cells were stained with Draq5
(Thermo Fisher Scientific) to determine toxicity and images were acquired by
Opera imaging system (PerkinElmer). Adose-responsecurvewasplottedusing
sigmoid regression analysis, and IC50 and CC50 were calculated.
Inhibition Shift Assay upon Genetic KO
HUH7 cells stably expressing Cas9 were dispensed into 384-wellplates at
4 3 103 cells/well and were treated with individual lentiviral packaged gRNAs
at an M.O.I. of !5. Cells were maintained under puromycin selection pres-
sure at 2mg/ml for 5 days. After this initial CRISPR/Cas9 mediated knock
out, cells were infected with DENV2 (MOI2) in the presence serial dilutions
of compounds. 48 hr later plates were processed and IC50 calculated as
described above in in the high-content imaging cell-based flavivirus immuno-
detection (HCI CFI) assay. IC50 fold-shift for each drug/gRNA combination
was calculated by dividing mean IC50 gRNA-treated with wild-type, mock-
treated cells. A two-way ANOVA allowing for multiple comparisons with a
Sidak correction was performed between NITD008 and cavinafungin for
each gRNA-treated sample using the logged IC50 fold-shift obtained in
GraphPad Prism v7.0.
Dengue Viral Titer Reduction Assay
53 105 cells per well of hPBMCs were seeded into 96-well plates, followed by
treatment with 4G2 antibody. The antibody-enhanced hPBMCs were infected
at an MOI 1 of DENV-2 (MY97-10340), and the infected cells were immediately
treated with 5-fold serial dilutions of the compounds. 1 3 105 cells per well
hHepIPS were seeded into 96-well plates and infected at an MOI 4 DENV-2
458 Cell Reports 19, 451–460, April 18, 2017
(MY97-10340) 5 days post-seeding. The infected cells were then treated with
3-fold serial dilutions of the compound. Culture fluids from DENV infections
were collected at 48 hr p.i. The viral titers in the collected samples were quan-
tified using a plaque assay.
Testing Other Viruses
Zika virus testing was performed at University of Texas Medical Branch
(UTMB) by the team of Pei-Yong Shi using a live reporter virus as reported
previously (Shan et al., 2016). Chikungunya testing was performed using a
live GFP-expressing infectious clone, LR-30-GFP-CHIKV, obtained from EVA
(European Virus Archive) as previously described (Tsetsarkin et al., 2006).
Genome-wide CRISPR/Cas9 Profiling Experiment
A previously described protocol (Estoppey et al., 2017) was followed.
Cavinafungin was tested at two sublethal doses, IC10 (450 nM) and
IC30 (600 nM), based on the best results from related chemogenomic profiling
experiments in yeast (Giaever et al., 1999; Hoepfner et al., 2014) and CRISPR
pilot experiments with other compounds (Estoppey et al., 2017). Detailed pro-
tocols for genomic DNA extraction, sequencing of the gRNA, and processing
of the data have been reported previously (Estoppey et al., 2017).
HIP HOP Profiling
Chemogenomic profiling and data processing of cavinafungin was conducted
as described previously (Hoepfner et al., 2014).
Focused Mutagenesis Approach
The focused mutagenesis screen was performed as described previously
(Huang et al., 2013), with slight modifications. In short, 107 yeast BY4743D8
cells (Hoepfner et al., 2012) carrying randomly mutagenized, plasmid-based
SEC11, SPC1, SPC2, or SPC3 variants, respectively, were plated on synthetic
minimal SD medium complemented with 150 mM cavinafungin and incubated
for 3 days at 30#C. Growing colonies were restreaked onto selective media.
Stably resistant clones were then isolated and amplified, and DNA was iso-
lated and subjected to Sanger sequencing.
Analysis of Viral and Host Protein Signal Cleavage
293T cells were transfected with pXJ constructs containing SPase processing
sites of the dengue virus polyprotein, C14-prM-E and 2K-NS4B-V5. C14 consists
of the last 14 aminoacids of the capsid, and 2K-NS4B-V5 represents the internal
signal peptide C terminal of NS4A followed by NS4B with a V5 tag. At 6 hr post-
transfection, the cells were treated with 1 mM cavinafungin, 1 mM cavinafungol,
or DMSO. Cells were lysed 24 hr later using RIPA buffer, and the clarified cell
lysates were analyzed by western blot using either polyclonal rabbit anti-prM
(GeneTex), polyclonal rabbit anti-E (GeneTex), or monoclonal mouse anti-
NS4B antibodies (in-house; Xie et al., 2014), respectively. The blots were also
probed with polyclonal rabbit anti-GAPDH antibody (Sigma) as a loading con-
trol. The bands were detected with ECL Western Blotting System (GE Health-
care) and imaged with ChemiDoc western blot imaging system (Bio-Rad).
Densitometry analysis was performed with Image Lab software (Bio-Rad),
curves were fitted using the logistic regression curve fit function in GraphPad
Prism version 7.00 (GraphPad Software), and weighted mean IC50 values and
weighted errors were calculated as described previously (Jones et al., 2010).
For metabolic labeling, HeLa a cells were transiently transfected with
C14-prM-E or 2K-NS4B-V5 in pXJ or with the cDNA of human pre-provaso-
pressin in the expression plasmid pRc/RSV using Fugene HD (Promega) and
used after 2 days. INS-1E insulinoma cells (Janjic et al., 1999) were grown in
RPMI medium and in addition 10 mM HEPES, 1 mM sodium pyruvate, and
20 mM b-mercaptoethanol. Cells were starved for 30 min in methionine/
cysteine-free medium and labeled for 40 min at 37#C in starvation medium
with 100 mCi/ml [35S]methionine/cysteine (Hartmann Analytics). Cavinafungin
or the reduced alcohol form was added. Cells were washed at 4#C, lysed,
and subjected to immunoprecipitation using a rabbit anti-provasopressin
(Friberg et al., 2004), a monoclonal mouse anti-proinsulin (CCI-17; HyTest), a
rabbit anti-prM (GeneTex), and an anti-V5 antibody (R960-25, Invitrogen),
respectively, and protein A-Sepharose. For 2K-NS4B-V5, the immunopre-
cipitates were sometimes digested with endoglycosidase H before SDS-gel
electrophoresis and autoradiography.
SEC11/SEC11A Complementation
The heterozygousSEC11/sec11D::kanMX4BY4743 strain from the official yeast
deletion collection was transformed with an integrative plasmid containing a
HIS3marker and the human SEC11A cDNA under control of the S.c. ADH1 pro-
moter. Successful transformants were subjected to sporulation and tetrad
dissection. Spores were analyzed for growth on media containing G418 or
lacking histidine. All G418-resistant spores also were prototroph for histidine.
Two independent clones (1Mat a and 1Mat alpha) were picked and correct inte-
gration and genotype confirmed by analytical PCR.
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Table 4: Chemicals used in this study. 
Name Company Solution/Concentration 
BSA Sigma-
Aldrich 

















Carbenicillin Applichem 50 mg/ml 
[35S]Methionine  Hartmann 
Analytics 
Storage solution: 50 mM Tricine (pH 7.4), 
stabilized 










Table 5: Antibodies used in this publication 
Name Supplier Host 


















Table 6: Bacterial strains and yeast strains. 
Name Genotype 
E.Coli Top 10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG 
recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ- 
S. cerevisiae 
RSY1293 










































7.4. Restriciton Enzymes 
 
Table 7: Restriction enzymes used in this publication. 
Restriction 
Enzyme 
Supplier Conditions Overhang 























































































Table 8: Buffers used in this study. 
Buffer Component Concentration 









LiACTE (10x) Lithium acetate pH 7.5 
Tris/HCl pH 7.5 
























































Sorbitol (1 M, pH 7.5) Sorbitol  




























DMEM   
Lysis-Buffer for cell line 
labeling 
  
IP-Buffer for cell line 
labeleling 
  






7.6. Cloning Strategies 
 
 
The constructs used in this work were created by using conventional cloning 
techniques, like polymerase chain reaction, restriction digestion and ligation.  
The plasmid used for cloning and expression in yeast is pRS426 (from N. Kralli, 
Scripps Institute, San Diego, CA). 
 
The construct RI-Sp125 was created by cloning the spectrin sequence out of the plasmid 
pRSETA-Sp16, a plasmid which we received from Prof. Jane Clarke (University of 
Cambridge).  
 













7.7. Yeast Transformation using the LiAc-Method 
 
Yeast cells were grown in YPD media at 30°C until an OD600 of 0.6 – 0.8. The cells 
were harvested, washed with 5 ml 1x LiAc and resuspended in 2 ml 1x LiAc. 50 µl of 
the prepared yeast suspension was used for a single transformation. The cells were 
mixed with 500 µg of DNA and 300 µl transformation solution, containing 100 µg SS 
DNA. The samples were heat shocked for 30 min at 42°C, followed by washing and 
resuspension in 1 M sorbitol solution, followed by plating on SD-URA plates. 
Transformants were obtained after incubation at 30°C for 3 – 4 days.  
 
 
7.8. Radiolabeling with [35S]Methionine/Cysteine in yeast 
 
Yeast transformants were inoculated in 3 ml YPD media overnight at 30°C. The next 
day, the OD600 of the overnight culture was measured via a photometer, adjusted to 0.6 
and regrown for 2 h in SD-URA media at 30°C. 1.5 ml of the cell suspension was 
harvested, resuspended in 150 µl SD-URA and incubated at 30°C for 15 min. The cells 
were in vivo pulse-labeled for 5 – 10 min with 150 µCi/mL [35S] methionine/cysteine 
(Perkin Elmer) at 30°C. Translation was stopped by adding 2.5 µl of a 1 M NaN3 
solution and putting the samples on ice. Cells were washed with 150 µl PBS and 
resuspended in 150 µl TEP, followed by cell lysis by adding 100 µl glass beads and 
vortexing for 5 – 10 min at 4°C. 150 µl TEP + 2 % SDS were added to the cells, heated 
at 95°C for 10 min, cleared by centrifugation and subjected to immunoprecipitation 
overnight in IP Buffer. The following day, 20 µl Sepharose A beads were added to the 
samples, incubated for 1 h at 4°C, washed three times with TNET buffer and 
resuspended in 50 µl 2x sample buffer. The probes were heated to 95°C for 10 minutes, 
loaded on an SDS-gel and run overnight. The gels were fixed and destained for 45 min 
by using the fixation buffer, followed by excessive washing with H2O. The gels were 
put onto whatman paper and dryed for 2 – 3 h. Afterwards, the dryed gels were put into 
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A. Internal initiation of protein synhesis 
 
 
A phenomenon observed in several construct series throughout this work was the 
appearance of a lower band that was shown to be sensitive to deglycosylation with 
EndoH, indicating that it is translocated into the lumen of the endoplasmic reticulum. 
C-terminal cleavage of the proteins could be excluded, since the immunoprecipitation 
was done with an antibody against the very C-terminal end of the protein. Another 
explanation for this lower band is, that protein synthesis is initiated at an internal 
methionine codon, resulting in a truncated version of the protein. For example, the full-
size protein of RI-DP124 is 92 kDa in size. A possible truncated version, with the 
methionine codon at position 149 acting as an internal start codon, would have a size 
of only 75 kDa. This size is in accordance with the bands height on the autoradiograph. 
Intriguingly, the truncated version of the model protein would act as a stop-transfer 
model protein, showing the characteristic pattern of stop-transfer glycosylation (Figure 
25 A, compare with Figure 10 C). The fully glycosylated form of the truncated version 
has a size of 96 kDa, thus appears in the autoradiographs slightly above the bands, 
representing the unglycosylated form of the full-size construct (92 kDa). This is also 
what we find on the autoradiograph (Figure 25 B). 
To further analyze, whether the methionine codon at position 149 is responsible for the 
lower band we mutated the methionine to an alanine in some of the constructs where 
the problem of internal initiation occurred. Upon expression of RI-DP124 and the 
methionine-less mutant RI-DP124 M149A of the constructs, the lower band vanished, 




Figure 25: A Schematic representation of the model protein (above) and the construct that is produced due to internal 
initiation of a start codon at position 149. B Autoradiograph of RI-DP124. The lower bands represent a pattern that 
is common for stop-transfer integration (compare to Figure 10), while the upper bands are representing re-
integration. C Autoradiograph of RI-DP124 and RI-DP124 M149A. The proteins were deglycosylated by 
endoglycosidase H after immunoprecipitation. The lower band below 80 kDa is does not appear for the mutant 


















The H-segment consists of 19 host alanines that are replaced with leucines to modulate 
the hydrophobicity of the domain. The H-segments used in this work are shown in the 
following list 
 
L00  GGPGAAAAAAAAAAAAAAAAAAAGPGG 
L01  GGPGAAAAAAAAALAAAAAAAAAGPGG   
L02  GGPGAAAALAAAALAAAAAAAAAGPGG 
L03  GGPGAAAALAAAALAAAALAAAAGPGG 
L04  GGPGAAAALALAALAAAALAAAAGPGG 
L05  GGPGAAAALALAALAALALAAAAGPGG 
L06  GGPGAAAALALALALALALAAAAGPGG 
L07  GGPGAAAALALALALALALALAAGPGG 
L08  GGPGAALALALALALALALALAAGPGG 
L09  GGPGAALALALALALALALALALGPGG 
L11  GGPGLLALALALALALALALALLGPGG 
L15  GGPGLLLALLLALLLALLLALLLGPGG 
L19  GGPGLLLLLLLLLLLLLLLLLLLGPGG 
 
 
The following list contains all the construct series used in this work. The signal anchor 
and the stop-transfer domain are highlighted in red and orange, the H-segment is 






































































































































































































































































































The following list contains all the constructs, used for Part II. The signal sequence is 
marked in red. The prM domain is highlighted in blue, the E domain in green. 
Concerning the construct 2K-NS4B-V5, the NS4B domain is marked in violet, the 
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